Log In

Forgot Password?

OR

Not a member? Continue as a nonmember.

Become a Member

By becoming a member of the AAN, you can receive exclusive information to help you at every stage of your career. Benefits include:

Join Now See All Benefits

Loading... please wait

2023 Annual Meeting | P13 - Poster Session 13

Thursday 04/27/23
08:00 AM - 09:00 AM EST Add To Calendar
This program will be presented both in-person and online
This program is not expected to be available in the meeting's On Demand product.
Scientific Poster Session
Neuro-oncology, Aging, Dementia, Cognitive, and Behavioral Neurology, Autoimmune Neurology, Child Neurology and Developmental Neurology, Education, Research, and Methodology, Epilepsy/Clinical Neurophysiology (EEG), General Neurology, Headache, Infectious Disease, Movement Disorders, Multiple Sclerosis, Neuro Trauma and Critical Care, Neuromuscular and Clinical Neurophysiology (EMG)
0.00 CME credit

Program Materials Program Evaluations

Event Timeline
08:00 AM - 09:00 AM EST Abstract 9-001 - Diagnosing Infantile Epileptic Spasms: Can Smartphone Videos Replace EEG in Resource-limited Settings?
Christine Shrock, MD
08:00 AM - 09:00 AM EST Abstract 9-002 - A paradigm shift in the diagnosis of Hypsarrythmia and its prognostic value in children with epileptic spasms
Yumiko Okahashi, MD, PhD
08:00 AM - 09:00 AM EST Abstract 9-003 - Increased Perirolandic Cortical Excitability May Facilitate Sensory Motor Mapping in Children
Majed Alzahrany, MBBS
08:00 AM - 09:00 AM EST Abstract 9-004 - The Utilization of EEG Monitoring in Premature Infants with High-Grade Intraventricular Hemorrhage
Khaled Al Robaidi, MD
08:00 AM - 09:00 AM EST Abstract 9-005 - EEG Findings in a Pediatric Patient with 3q29 Microdeletion Syndrome
Irfan Sahail Sheikh, MD
08:00 AM - 09:00 AM EST Abstract 9-006 - Trends in COA Use and Regulatory Acceptance for Epileptic Encephalopathy and Developmental Epileptic Encephalopathy Indications
Christina Graham
08:00 AM - 09:00 AM EST Abstract 9-007 - Efficacy and Safety of Fenfluramine in Lennox-Gastaut Syndrome: A Systematic Review
Bakhtawar Ahmad, MBBS
08:00 AM - 09:00 AM EST Abstract 9-008 - A Case Series in the Use of Topiramate for Neonatal Seizures
Cynthia Zheng, MD
08:00 AM - 09:00 AM EST Abstract 9-009 - Anti-epileptic Prophylaxis for Early or Late Post-traumatic Seizures in Children with Traumatic Brain Injury: A Systematic Review
Obada Ahmad Al Jayyousi, MD
08:00 AM - 09:00 AM EST Abstract 9-010 - Seizures in the Contralateral hemisphere in Rasmussen Encephalitis after Disconnective hemispherectomy – True or False lateralizing?
Prashant Natteru, MBBS
08:00 AM - 09:00 AM EST Abstract 9-011 - Real-world Outcomes of Cannabidiol For The treatment of Refractory Epilepsy in Pediatric Patients
Ismail Mohammed Fahad, MBBS
08:00 AM - 09:00 AM EST Abstract 15-001 - Teaching neurologists through microlearning: the first 4 years of the eLearning experience with NeuroBytes
Adam Quick, MD
08:00 AM - 09:00 AM EST Abstract 15-002 - Addressing Deficiencies in Knowledge and Skills Regarding the Management of Women with Multiple Sclerosis Throughout the Reproductive Years
Emily Scully
08:00 AM - 09:00 AM EST Abstract 15-003 - Continuing Medical Education Increases Knowledge, Competence, and Confidence Related to the Use of Non-Oral Acute Migraine Therapies Among Neurologists
Christine Considine
08:00 AM - 09:00 AM EST Abstract 15-004 - Curriculum-based CME-certified Migraine Programming Results in Comprehensive Improvements Across The Care Spectrum for Neurologists
Piyali Chatterjee
08:00 AM - 09:00 AM EST Abstract 15-005 - Quality Improvement of Quality Improvement
Elizabeth Monohan, MD
08:00 AM - 09:00 AM EST Abstract 15-006 - A Quality Improvement Strategy to Improve Recognition and Identification of Atypical Stroke Presentations in the Pre-Hospital Setting
Cleo Zarina Alejo Reyes, MD
08:00 AM - 09:00 AM EST Abstract 3-001 - Experimental Improvement of Attention / Cognitive Speed Does Not Improve Memory in Multiple Sclerosis
Emily Dvorak
08:00 AM - 09:00 AM EST Abstract 3-002 - Cognitive and MRI Profiles in Primary and Secondary Progressive Multiple Sclerosis
Laura Cacciaguerra, MD, PhD
08:00 AM - 09:00 AM EST Abstract 3-003 - Integration of the Expanded Disability Status Scale with ambulation, visual and cognitive tests improves disability assessment
Francesco Sacca, MD
08:00 AM - 09:00 AM EST Abstract 3-004 - Cognitive impairment in relapsing remitting multiple sclerosis patients: the role of white matter.
Mahmoud Elkhooly, MD
08:00 AM - 09:00 AM EST Abstract 3-005 - Declines in Work Productivity in Persons With Multiple Sclerosis by PDDS Score
Caroline K. Geiger, PhD
08:00 AM - 09:00 AM EST Abstract 3-006 - Impact of Early-stage Relapsing Remitting Multiple Sclerosis on Quality of Life
Tamara Castillo-Trivino, MD, MAS, FAAN
08:00 AM - 09:00 AM EST Abstract 3-007 - Disability progression and worse cognitive status are associated with higher concurrent brain atrophy rates
Maria Alejandra Garcia-Dominguez, MD
08:00 AM - 09:00 AM EST Abstract 3-008 - Slow information processing speed elucidates impairment in executive function tests in people with Multiple Sclerosis
Maria Sol Román
08:00 AM - 09:00 AM EST Abstract 3-009 - EDSS and MS duration is associated with cognitive impairment in a large Argentinian cohort of patient with multiple sclerosis
Barbara Eizaguirre
08:00 AM - 09:00 AM EST Abstract 3-010 - The MS-LINK Outcomes Study Cohort: Study design and a descriptive analysis of baseline key PROs, disease, and sociodemographic characteristics
Jeffrey B. English, MD
08:00 AM - 09:00 AM EST Abstract 3-011 - Severity of Symptoms Among Persons With Multiple Sclerosis by PDDS Score
Nicole Gidaya Bonine, PhD
08:00 AM - 09:00 AM EST Abstract 3-014 - Characterizing the Contribution of White Matter on Ambulation in Relapsing Multiple Sclerosis
Cristina Jageka, MD
08:00 AM - 09:00 AM EST Abstract 3-015 - Cognitive-motor interaction: relationship with employment status in relapsing-remitting multiple sclerosis
Barbara Eizaguirre
08:00 AM - 09:00 AM EST Abstract 3-016 - In early MS, the vasopressin peptide copeptin in serum is not a suitable surrogate for hypothalamo-pituitary-adrenal axis activity
Maike Schlingmann
08:00 AM - 09:00 AM EST Abstract 3-017 - Race and Social Determinants of Health in Performance Outcomes among Relapsing Remitting Multiple Sclerosis Patients
Justin Abbatemarco, MD
08:00 AM - 09:00 AM EST Abstract 3-018 - Sexual Behavior and Multiple Sclerosis
Matthew Robert Kennis
08:00 AM - 09:00 AM EST Abstract 12-001 - Michigan Neuropathy Screening Instrument: A tool for diabetic peripheral neuropathy diagnosis in a rural area in Ecuador.
Daniella Alejandra Bustamante, MD
08:00 AM - 09:00 AM EST Abstract 12-002 - Acute, Transient, Brain Lesions on Magnetic Resonance Imaging in X-linked Charcot-Marie-Tooth type 1
Kholoud Yaser Altarazi, MD
08:00 AM - 09:00 AM EST Abstract 12-003 - Severe Porphyric Neuropathy: A Tale of Two Challenging Cases
Erin Harrison Britt, MD
08:00 AM - 09:00 AM EST Abstract 12-004 - Effect of complement C3 inhibition with pegcetacoplan in an iPSC-derived ALS neuromuscular junction model of neuroinflammation
Yan Li, PhD
08:00 AM - 09:00 AM EST Abstract 12-005 - Immunosuppression Status Did Not Affect COVID-19 Incidence in a Retrospective Survey of Myasthenia Gravis Patients
Amanda Breaux, MD
08:00 AM - 09:00 AM EST Abstract 12-006 - Role of the Pharmacist in Monitoring Patients Receiving Oral Edaravone for Amyotrophic Lateral Sclerosis
Christine Miller, PharmD
08:00 AM - 09:00 AM EST Abstract 12-007 - Female Binge Drinkers may be at Higher Risk of Acute Alcoholic Neuropathy
Angelica Carolina Cornejo, MD
08:00 AM - 09:00 AM EST Abstract 6-001 - Temporal Relationship of Breast Cancer and Paraneoplastic Neuromyelitis Optica Spectrum Disorder (NMOSD)
Shravan Sivakumar, MBBS
08:00 AM - 09:00 AM EST Abstract 6-002 - Long-term Safety of Satralizumab in Adults with Aquaporin-4-IgG-seropositive (AQP4-IgG+) Neuromyelitis Optica Spectrum Disorder (NMOSD): Results from SAkuraMoon
Shervin Gholizadeh
08:00 AM - 09:00 AM EST Abstract 6-003 - Safety and Efficacy of Inebilizumab in AQP4+ NMOSD Participants with History of Immunosuppression Treatment Prior to N-MOmentum Study
Friedemann Paul
08:00 AM - 09:00 AM EST Abstract 6-004 - Misdiagnosis of Multiple Sclerosis in Neuromyelitis Optica: Results from multi-institutional database analysis from the United States
Ka-Ho Wong
08:00 AM - 09:00 AM EST Abstract 6-005 - A Phase II, Randomized, Double-blind, Sham-Controlled Clinical Trial of Transcutaneous Electrical Nerve Stimulation (TENS) Therapy for the Treatment of Neuropathic Pain in Neuromyelitis Optica Spectrum Disorders
Anastasia Vishnevetsky, MD
08:00 AM - 09:00 AM EST Abstract 6-006 - Metabolomics profiling implicates altered lipid metabolism in neuromyelitis optica spectrum disorder
Elina Misicka, PhD
08:00 AM - 09:00 AM EST Abstract 6-007 - Patient Experience and Quality of Life in Mexican Patients with Neuromyelitis Optica Spectrum Disorder: A Sub-analysis of an International Multicenter Cross-sectional Survey in Latin America
Enrique Gomez Figueroa, MD, MSc
08:00 AM - 09:00 AM EST Abstract 6-008 - Characterization of HLA Class II Alleles in Patients with Neuromyelitis Optica in Bogotá, Colombia
Jaime Toro, MD, FAAN
08:00 AM - 09:00 AM EST Abstract 6-009 - Acute NMOSD Attack in the Setting of Pembrolizumab Therapy: A Case Report
Margaret Elizabeth Upchurch, MD
08:00 AM - 09:00 AM EST Abstract 6-010 - Satralizumab Treatment in Adult Patients With AQP4-IgG–Seropositive Neuromyelitis Optica Spectrum Disorder: A Case Series
Hesham Ahmed Abboud, MD
08:00 AM - 09:00 AM EST Abstract 6-011 - Characterizing the Impact of NMOSD on Mobility, Daily Activities, and Social Activities Through Patient Interviews
Evanthia Bernitsas, MD, FAAN
08:00 AM - 09:00 AM EST Abstract 6-013 - A Case of Seronegative NMOSD-Related Myelitis Masquerading as VZV-Related Myelitis
Qasem N. Alshaer, MD
08:00 AM - 09:00 AM EST Abstract 6-014 - Neuromyelitis Optica Spectrum Disorder Mimicking Pontine Stroke - A Cautionary Tale: Case Report and Systematic Literature Review
Brendan Huang, MD
08:00 AM - 09:00 AM EST Abstract 6-015 - Inebilizumab Reduces Attack Risk Independent of Low Affinity IgG Fc Region Receptor III-A Gene Polymorphisms in Neuromyelitis Optica Spectrum Disorder
Brian G. Weinshenker, MD, FAAN
08:00 AM - 09:00 AM EST Abstract 6-016 - Association of Disease Characteristics with Utilization of Behavioral Medicine in Patients with NMOSD and MOGAD
Carol Swetlik, MD
08:00 AM - 09:00 AM EST Abstract 6-017 - Real-world data on eculizumab treatment in NMOSD: high efficacy and potential challenges
Ilya Ayzenberg
08:00 AM - 09:00 AM EST Abstract 6-018 - Comparison of visual acuity recovery in 3-,5-, and 7-day schedules of intravenous methylprednisolone in patients with optic neuritis: a case-control study
Samira Apostolos-Pereira
08:00 AM - 09:00 AM EST Abstract 6-019 - Real-world application of the updated criteria of optic neuritis
Samira Apostolos-Pereira
08:00 AM - 09:00 AM EST Abstract 6-020 - MOG antibody-associated encephalitis in adult: clinical phenotypes and outcomes
Soon-Tae Lee, MD, PhD
08:00 AM - 09:00 AM EST Abstract 6-021 - Spinal Glioblastoma Mimicking Myelin Oligodendrocyte Glycoprotein Antibody Disease Transverse Myelitis
Ada Breitenbucher, MD
08:00 AM - 09:00 AM EST Abstract 6-022 - Clinical and Radiologic Features of a Cohort of Adult and Pediatric Patients in the Pacific Northwest with Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease (MOGAD)
Kayla Martin, MD
08:00 AM - 09:00 AM EST Abstract 6-023 - Comparing Lesion Distribution on Presentation of Pediatric and Adult Patients with MOG Antibody-Associated Disease (MOGAD)
Ibrahim Ahmad
08:00 AM - 09:00 AM EST Abstract 6-024 - FLAIR-hyperintense lesions in anti-MOG-associated Encephalitis with Seizures (FLAMES) mimicking new daily persistent headache. Updating the diagnostic paradigm with recommendations for timely diagnosis and management.
Nara Michaelson, MD
08:00 AM - 09:00 AM EST Abstract 6-025 - Cognitive sequelae in MOG antibody-associated disease
Xiaoyang Li, MD
08:00 AM - 09:00 AM EST Abstract 6-026 - Placental transmission of MOG-IgG to neonate from mother with MOGAD
Vyanka Redenbaugh, MB BCh BAO
08:00 AM - 09:00 AM EST Abstract 6-027 - Healthcare Utilization of Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease Patients
Kelsey Stefan, MD
08:00 AM - 09:00 AM EST Abstract 6-028 - Timing and Predictors of T2-Lesion Resolution in MOGAD
Laura Cacciaguerra, MD, PhD
08:00 AM - 09:00 AM EST Abstract 6-029 - Treatment Response Variation in Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease presenting as Acute Disseminated Encephalomyelitis: Two Case Illustrations.
Milena Lobaina, MD
08:00 AM - 09:00 AM EST Abstract 6-030 - Prognostic Factors in Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease: Single Center Experience
Murat Kurtuncu, MD
08:00 AM - 09:00 AM EST Abstract 6-031 - Myelin Oligodendrocyte Glycoprotein Antibody Disease (MOGAD) in conjunction with Allogeneic Bone Marrow Transplantation and Autoimmune Neutropenia: A study of two companion cases and institutional review of the MOGAD clinical phenotype spectrum
Esther H. Nie, PhD
08:00 AM - 09:00 AM EST Abstract 7-001 - Memory Performance in Asymptomatic and Prodromal Familial Frontotemporal Lobar Degeneration: Findings from the ALLFTD Consortium
Bradley F. Boeve, MD, FAAN
08:00 AM - 09:00 AM EST Abstract 7-002 - EEG correlates in the three variants of Primary Progressive Aphasia
Edoardo G. Spinelli, MD
08:00 AM - 09:00 AM EST Abstract 7-003 - FTD Disorders Registry (FTDDR) Research Readiness Survey: Assessing awareness and attitudes to increase research participation
Sherry Harlass, Other
08:00 AM - 09:00 AM EST Abstract 7-004 - Semantic Variant Primary Progressive Aphasia Associated with the C9orf72 Hexanucleotide Expansion – A Longitudinal Case Report
Aaron Ross Switzer, MSc
08:00 AM - 09:00 AM EST Abstract 7-005 - Cognitive correlates of ADL impairment in Lewy body dementia
Nidhi Desai
08:00 AM - 09:00 AM EST Abstract 7-006 - Clinical Predictors of Survival in Probable Dementia with Lewy Bodies
Stuart McCarter, MD
08:00 AM - 09:00 AM EST Abstract 7-007 - Correlates of Fluctuations in Moderate-Advanced Dementia with Lewy Bodies
Tracy Tholanikunnel, MD
08:00 AM - 09:00 AM EST Abstract 7-008 - Imaging regional histone deacetylase expression in dementia with Lewy bodies with [11C]Martinostat
Anna Goodheart, MD
08:00 AM - 09:00 AM EST Abstract 7-009 - Characterizing a Language Phenotype of Dementia with Lewy Bodies: A Clinicopathological Series
Camille Merhi, MD
08:00 AM - 09:00 AM EST Abstract 1-001 - Reduced abundance of Akkermansia muciniphila in Delayed Cerebral Ischemia following Subarachnoid Hemorrhage
James Walker Wiggins, MD, PhD
08:00 AM - 09:00 AM EST Abstract 1-002 - Fingolimod Reduces Cardiac Macrophage Infiltration after Experimental Subarachnoid Hemorrhage
Joseph Ryan Geraghty
08:00 AM - 09:00 AM EST Abstract 1-003 - A Machine Learning Tool to Predict Cerebral Vasospasm in Patients with Aneurysmal Subarachnoid Hemorrhage
Dhruv Patel
08:00 AM - 09:00 AM EST Abstract 1-004 - Refractory intracranial pressure elevation (ICP) treatment in acute aneurysmal subarachnoid hemorrhage via the novel neurapharesis CSF management system
Marc Alain Babi, MD
08:00 AM - 09:00 AM EST Abstract 1-005 - Characterizing the Use of Intrathecal Nicardipine for Post Traumatic Cerebral Vasospasm
Erika Sigman, MD
08:00 AM - 09:00 AM EST Abstract 1-006 - Decreased Timing to Vasospasm Prevention Medication Improves Outcomes Among Patients with Aneurysmal Subarachnoid Hemorrhage on Prehospital CCBs, ARBs, or ACE-inhibitors
Yasaman Pirahanchi, MD
08:00 AM - 09:00 AM EST Abstract 10-001 - Femoral Neuropathy: A Comprehensive Clinical and Electrodiagnostic Review
Ashley Santilli, MD
08:00 AM - 09:00 AM EST Abstract 10-002 - A Case of Mononeuopathy Multiplex in the Setting of Durvalumab Therapy
Abby Scurfield, MD
08:00 AM - 09:00 AM EST Abstract 10-003 - Bilateral Sequential Brachial Plexus Neuritis Following Immune Checkpoint Inhibitor Combination Treatment
Osman Ozel, MD
08:00 AM - 09:00 AM EST Abstract 10-004 - Skin Denervation Occurrence in Patients with Small Fiber Neuropathy Associated Symptoms Following Covid19 Vaccination and Infection
Mailam Eltity
08:00 AM - 09:00 AM EST Abstract 10-005 - Neuromuscular respiratory dysfunction due to vitamin B12 deficiency: a case report
Ahmed Ibrahim, MBBCH
08:00 AM - 09:00 AM EST Abstract 10-007 - POEMS syndrome associated with vitiligo
Avi Landman, MD
08:00 AM - 09:00 AM EST Abstract 10-008 - Severe Tibial Neuropathy and Myonecrosis After Prolonged Surgery in Lithotomy Position
Sebnem Nash, NP
08:00 AM - 09:00 AM EST Abstract 10-009 - A Case of Acute Motor Sensory Axonal Neuropathy, a Rare Form of Guillain-Barre Syndrome, Developing After Multiple COVID-19 Infections
Abhijit Rao
08:00 AM - 09:00 AM EST Abstract 10-010 - FOSMN Syndrome Presenting with Bulbar Onset Preceding Trigeminal Sensory Loss
Adam Uppendahl
08:00 AM - 09:00 AM EST Abstract 10-011 - Atypical presentation of Miller Fisher Syndrome
Milena Lobaina, MD
08:00 AM - 09:00 AM EST Abstract 10-012 - Severe painful neuropathy as the presenting feature of POEMS syndrome
Thiago Duque Pinheiro, MD
08:00 AM - 09:00 AM EST Abstract 10-013 - Microscopic Polyangiitis Mimicking Chronic Inflammatory Demyelinating Polyneuropathy
Eric Stulberg, MD
08:00 AM - 09:00 AM EST Abstract 10-014 - When To Use CSI (Combined Senory Index) in Electro-diagnostic Testing for Carpal Tunnel Syndrome (CTS)
Joseph Francis Imbs, IV, DO
08:00 AM - 09:00 AM EST Abstract 10-015 - Characteristics of a single-center cohort of patients with hereditary transthyretin amyloidosis
Nicolas Sarmiento Bustamante
08:00 AM - 09:00 AM EST Abstract 4-001 - Clinical Implications of Genetic Testing in Adults with Neurodevelopmental Disabilities (NDD)
Kaitlin Christine Smith, Other
08:00 AM - 09:00 AM EST Abstract 4-002 - High Sensitivity for Monogenic Causal Diagnoses in Autism, Including De Novo Variants Representing Novel Disorders, with Trio Whole Genome Sequencing and Data Reanalysis in a Non-Academic Center
Omri Bar
08:00 AM - 09:00 AM EST Abstract 4-003 - Whole Genome Sequencing to Resolve the Genomic Architecture of Cerebral Palsy in a Canadian Cohort
Maryam Oskoui, MD, FAAN
08:00 AM - 09:00 AM EST Abstract 4-004 - Elevated Healthcare Resources Utilization and Costs among Individuals Diagnosed with Rett syndrome
Damian Michael May, Other
08:00 AM - 09:00 AM EST Abstract 4-005 - Trofinetide for the treatment of Rett syndrome: an open-label study in girls 2 to 4 years of age
Alan K. Percy, MD, FAAN
08:00 AM - 09:00 AM EST Abstract 4-006 - Treatment with trofinetide shows benefit compared to placebo for the ability to communicate in individuals with Rett syndrome: a secondary analysis of the LAVENDER study
Alan K. Percy, MD, FAAN
08:00 AM - 09:00 AM EST Abstract 4-007 - Evaluation of Clinical Findings and Molecular Genetic Results of the Patients with CACNA1A Variants: Single Center Experience
Sinem Seleme Ovunc, MD
08:00 AM - 09:00 AM EST Abstract 4-008 - Autistic Burnout: A Report of Treatment Success
Elijah W Hale
08:00 AM - 09:00 AM EST Abstract 4-009 - Hereditary Spastic Paraparesis presenting as a Cerebral Palsy Mimic via Telemedicine
Dylan Franco Del Papa, MD
08:00 AM - 09:00 AM EST Abstract 4-010 - A Qualitative Analysis of Transition from Pediatric to Adult Care for Patients with Autism and Intellectual Disabilities
Sydney Carter
08:00 AM - 09:00 AM EST Abstract 4-011 - Human Cerebellar Expression of Autism Associated Genes
Seema Balasubramaniam, MBBS
08:00 AM - 09:00 AM EST Abstract 4-012 - Utilizing an EMR Tool to Demonstrate Increased Feasibility of Autism Diagnosis
Douglas Aaron Wells, Jr., MD
08:00 AM - 09:00 AM EST Abstract 13-001 - Vascular Age and Cognitive Outcomes in an Acute HIV Cohort After Six Years of ART
Kathryn Holroyd, MD
08:00 AM - 09:00 AM EST Abstract 13-002 - Neurosyphilis with Atypical CNS Lesions in HIV Patient Show Marked Response to Penicillin
Ilana Green, MD
08:00 AM - 09:00 AM EST Abstract 13-003 - Neuroimaging Features and Outcomes of Progressive Multifocal Leukoencephalopathy (PML): A Single-Center Experience
Hongxuyang Yu, MD
08:00 AM - 09:00 AM EST Abstract 13-004 - Progressive Multifocal Leukoencephalopathy Secondary to Possible Covert Administration of Osimertinib, a Case Report.
Brook Centofanti, DO
08:00 AM - 09:00 AM EST Abstract 13-005 - Fatal Isolated Brainstem Lesion in a Patient With Progressive Multifocal Leukoencephalopathy
Jordan Gregory Gates, DO
08:00 AM - 09:00 AM EST Abstract 5-001 - Deep Brain Stimulation in Woodhouse Sakati Syndrome: A Single Institution Retrospect Analysis
Yara O. Alkhodair, Jr., MBBS
08:00 AM - 09:00 AM EST Abstract 5-002 - Enabling Opioid Dose Reduction for Refractory Restless Legs Syndrome through Adjunctive Tonic Motor Activation (TOMAC) Therapy
Jonathan Charlesworth, PhD
08:00 AM - 09:00 AM EST Abstract 5-003 - Movement Disorders Associated with Cerebral Artery Stenosis: A Nationwide Study
Sun Ju Chung, MD, PhD, FAAN
08:00 AM - 09:00 AM EST Abstract 5-004 - Use of Liver Transplantation for Pure Neurologic Indications in Wilson Disease
Sarah Marmol, MD
08:00 AM - 09:00 AM EST Abstract 5-005 - The Clinical And Molecular Spectrum Of ZFYVE26-Associated Hereditary Spastic Paraplegia (SPG15)
Afshin Saffari, MD
08:00 AM - 09:00 AM EST Abstract 5-006 - Late-onset POLR3-related Leukodystrophy: report of a novel compound heterozygous mutation in the POLR3A gene and review of the phenotype
Laura Andrea Pesantez Pacheco, MD
08:00 AM - 09:00 AM EST Abstract 5-007 - Caspr2 Antibody-Mediated Ataxia, Parkinsonism, and Epilepsy: A Case for Escalating Immunotherapy.
Dana Alyse Sugar, MD
08:00 AM - 09:00 AM EST Abstract 5-008 - Predictors of good and bad outcomes of hematopoietic stem cell transplantation in CSF1R-related leukoencephalopathy
Jaroslaw Dulski
08:00 AM - 09:00 AM EST Abstract 5-010 - Anti-neuroinflammation effect of zonisamide in early Parkinson’s disease: A chronological PET study
Takashi Matsudaira, MD,PhD
08:00 AM - 09:00 AM EST Abstract 5-011 - Initiating dopamine agonists rather than levodopa in early Parkinson’s disease does not delay the need for DBS.
Diana Angelika Olszewska, MD, PhD
08:00 AM - 09:00 AM EST Abstract 5-014 - Intrajejunal Levodopa Infusion for Parkinson's Disease over 11 years: A Canadian Experience
Oksana Suchowersky, MD, FAAN
08:00 AM - 09:00 AM EST Abstract 5-015 - Impact of Istradefylline on Levodopa Dose Escalation in Parkinson’s Disease: Results of the ISTRA ADJUST PD Randomized, Controlled Study
Taku Hatano, MD
08:00 AM - 09:00 AM EST Abstract 5-016 - Use of Real-World Data to Evaluate the Importance of Antiemetic Pretreatment for Apomorphine hydrochloride [APO, Apokyn®] subcutaneous Injection Initiation and Maintenance in People with Parkinson Disease
Mindy Grall, PhD, NP
08:00 AM - 09:00 AM EST Abstract 2-001 - Efficacy of AXS-07 (MOSEIC™ Meloxicam and Rizatriptan) in Patients with Risk Factors for Inadequate Response to Acute Migraine Medications
Stewart J. Tepper, MD
08:00 AM - 09:00 AM EST Abstract 2-002 - Safety and Efficacy of Concomitant Erenumab and INP104 Use From the Phase 3 STOP 301 Study in Migraine Patients
Sheena K. Aurora, MD
08:00 AM - 09:00 AM EST Abstract 2-003 - Interim Analysis of Subject Impression Data for STS101 From the Phase 3 Open-Label ASCEND Study
Jessica Ailani, MD, FAAN
08:00 AM - 09:00 AM EST Abstract 2-004 - Interim Analysis of Long-Term Safety and Tolerability Data of STS101 From the Phase 3 Open-Label ASCEND Study
Stewart J. Tepper, MD
08:00 AM - 09:00 AM EST Abstract 2-005 - Consistency of Response to Liquid Celecoxib in Adults With Migraine: Post Hoc Analysis of Results From Two Randomized, Placebo-Controlled Studies
Daniel Serrano, PhD
08:00 AM - 09:00 AM EST Abstract 2-006 - Interim Analysis of STS101 Nasal Safety Data From the Phase 3 Open-Label ASCEND Migraine Study
Egilius L H Spierings, MD,PhD
08:00 AM - 09:00 AM EST Abstract 2-007 - Real-World Effectiveness of Fremanezumab in Patients with Migraine who Switched From Another mAb Targeting the CGRP Pathway (Subgroup Analysis From FINESSE)
Lynda Krasenbaum
08:00 AM - 09:00 AM EST Abstract 2-009 - Lack of “wearing off” effect with eptinezumab in the preventive treatment of migraine
Divya Asher
08:00 AM - 09:00 AM EST Abstract 2-010 - Fremanezumab for Migraine Prevention: Interim Analysis of the Non-Interventional FINESSE Study
Lynda Krasenbaum
08:00 AM - 09:00 AM EST Abstract 2-011 - Effect of Eptinezumab on Utility Scores in Patients with Migraine: Results from the DELIVER Study
Stephane Regnier, PhD
08:00 AM - 09:00 AM EST Abstract 2-012 - Impact of eptinezumab on work productivity beyond reductions in monthly migraine days: Post hoc analysis of the DELIVER trial
Piero Barbanti, MD
08:00 AM - 09:00 AM EST Abstract 11-001 - GESTALT (GammaTile Enhanced Stupp Alternative): Feasibility Study of Resection and GammaTile® Followed by Concomitant External Beam Radiation Therapy (EBRT)/Temozolomide (TMZ) and Adjuvant TMZ in Newly Diagnosed Glioblastoma (GBM)
Erin M. Dunbar, MD
08:00 AM - 09:00 AM EST Abstract 11-002 - Prognostic Markers in Glioblastoma Patients Treated with Temozolomide
Nadia McMillan, MD, PhD
08:00 AM - 09:00 AM EST Abstract 11-003 - Molecular markers impacting survival in patients receiving concurrent chemoradiation and Tumor-Treating Fields (TTF) in patients with newly diagnosed glioblastoma: secondary analysis of SPARE trial
Allison Nancy Kayne
08:00 AM - 09:00 AM EST Abstract 11-004 - Survival and Clinical Characteristics of Patients with Glioblastoma with Primitive Neuronal Component
Tresa McGranahan, MD
08:00 AM - 09:00 AM EST Abstract 11-005 - Investigating the Effects of Tumor Treating Fields and Genetic Mutations in Patients With Glioblastoma
Andy Yu-Der Wang, MD
Faculty Disclosures
Sooyeoun You Sooyeoun You has nothing to disclose.
Sang Kun Lee, MD Prof. Lee has nothing to disclose.
David N. Lieberman, MD, PhD Dr. Lieberman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Acadia Pharmaceuticals. Dr. Lieberman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Taysha Gene Therapies. Dr. Lieberman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neurogene.
Veronica Rivas Veronica Rivas has nothing to disclose.
Clemens Warnke The institution of Clemens Warnke has received research support from Novartis. The institution of Clemens Warnke has received research support from Alexion. The institution of Clemens Warnke has received research support from Sanofi-Genzyme. The institution of Clemens Warnke has received research support from Biogen. The institution of Clemens Warnke has received research support from Roche.
Umer Hassan, MBBS Dr. Hassan has nothing to disclose.
Mona Darwish, PhD Dr. Darwish has received personal compensation for serving as an employee of Acadia.
Yara O. Alkhodair, Jr., MBBS Dr. Alkhodair has nothing to disclose.
Peter Tsai, MD, PhD The institution of Dr. Tsai has received research support from once upon a time foundation.
Ronald C. Petersen, PhD, MD, FAAN Dr. Petersen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Petersen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech. Dr. Petersen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Nestle. Dr. Petersen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eli Lilly and Co.. Dr. Petersen has received personal compensation in the range of $0-$499 for serving as a Consultant for Eisai, Inc.. Dr. Petersen has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech, Inc.. Dr. Petersen has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche, Inc.. Dr. Petersen has received publishing royalties from a publication relating to health care. Dr. Petersen has received publishing royalties from a publication relating to health care. Dr. Petersen has received publishing royalties from a publication relating to health care. Dr. Petersen has a non-compensated relationship as a Board of Directors with American Brain Foundation that is relevant to AAN interests or activities.
Gregory S. Day, MD, MSc, FAAN Dr. Day has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Parabon Nanolabs. The institution of Dr. Day has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Eli Lilly. Dr. Day has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Arialys Therapeutics. Dr. Day has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for DynaMed (EBSCO Health). Dr. Day has stock in ANI Pharmaceuticals. The institution of Dr. Day has received research support from National Institutes of Health / NIA. The institution of Dr. Day has received research support from Chan Zuckerberg Initiative. The institution of Dr. Day has received research support from Alzheimer's Association. The institution of Dr. Day has received research support from National Institutes of Health / NINDS. The institution of Dr. Day has received research support from Horizon Therapeutics. The institution of Dr. Day has received research support from AVID Radiopharmaceuticals. Dr. Day has received personal compensation in the range of $500-$4,999 for serving as a Presenter at Annual Meeting (CME) with American Academy of Neurology. Dr. Day has received personal compensation in the range of $500-$4,999 for serving as a Content Development (CME) with PeerView, Inc. Dr. Day has received personal compensation in the range of $5,000-$9,999 for serving as a Content Development (CME) with Continuing Education, Inc. Dr. Day has a non-compensated relationship as a Clinical Director with AntiNMDA Receptor Encephalitis Foundation that is relevant to AAN interests or activities.
Fabio Nascimento, MD Dr. Nascimento has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Zogenix. The institution of Dr. Nascimento has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biocodex. Dr. Nascimento has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for AAN. Dr. Nascimento has received publishing royalties from a publication relating to health care. Dr. Nascimento has a non-compensated relationship as a Editorial Team Member with Neurology RFS that is relevant to AAN interests or activities. Dr. Nascimento has a non-compensated relationship as a Production Team with Neurology Podcast that is relevant to AAN interests or activities.
Zachary N. London, MD, FAAN Dr. London has nothing to disclose.
Jessica Ailani, MD, FAAN Dr. Ailani has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Allergan/Abbvie. Dr. Ailani has received personal compensation in the range of $0-$499 for serving as a Consultant for Amgen. Dr. Ailani has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Eli Lilly. Dr. Ailani has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Lundbeck. Dr. Ailani has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Satsuma. Dr. Ailani has received personal compensation in the range of $500-$4,999 for serving as a Consultant for GlaxoSmithKline. Dr. Ailani has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Pfizer. Dr. Ailani has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Gore. Dr. Ailani has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ipsen. Dr. Ailani has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merz. Dr. Ailani has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Theranica. Dr. Ailani has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neurolief. Dr. Ailani has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Scilex. Dr. Ailani has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Dr. Reddy. Dr. Ailani has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Linpharma. Dr. Ailani has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eneura. Dr. Ailani has received personal compensation in the range of $50,000-$99,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Allergan/Abbvie. Dr. Ailani has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Aeon. Dr. Ailani has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Eli Lilly. Dr. Ailani has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Linpharma. Dr. Ailani has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Aeon. Dr. Ailani has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Current Pain and Headache Report. Dr. Ailani has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Medscape. The institution of Dr. Ailani has received research support from Satsuma. The institution of Dr. Ailani has received research support from Ipsen. The institution of Dr. Ailani has received research support from Parema. Dr. Ailani has received personal compensation in the range of $500-$4,999 for serving as a Medical Advisor with SELF.
Sean J. Pittock, MD Dr. Pittock has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech, Inc.. Dr. Pittock has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sage Therapeutics, Inc.. The institution of Dr. Pittock has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Astellas. Dr. Pittock has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Prime Therapeutics. Dr. Pittock has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB. Dr. Pittock has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche/Genentech. The institution of Dr. Pittock has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. The institution of Dr. Pittock has received personal compensation in the range of $500-$4,999 for serving as a Consultant for MedImmune/Viela Bio. Dr. Pittock has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Arialys Therapeutics. The institution of Dr. Pittock has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche/Genentech. Dr. Pittock has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB, Inc. Dr. Pittock has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Hoffman/LaRoche AG. Dr. Pittock has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genetech. Dr. Pittock has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for F. Hofman/LaRoche. The institution of Dr. Pittock has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. The institution of Dr. Pittock has received research support from Grifols. The institution of Dr. Pittock has received research support from NIH. The institution of Dr. Pittock has received research support from Viela Bio/MedImmune/Horizon. The institution of Dr. Pittock has received research support from Alexion Pharmaceuticals. The institution of Dr. Pittock has received research support from F. Hoffman/LaRoche/Genentech. The institution of Dr. Pittock has received research support from NovelMed. The institution of Dr. Pittock has received research support from AstaZeneca. Dr. Pittock has received intellectual property interests from a discovery or technology relating to health care. Dr. Pittock has received intellectual property interests from a discovery or technology relating to health care.
Amaal J. Starling, MD, FAAN Dr. Starling has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Axsome Therapeutics. Dr. Starling has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Lundbeck. Dr. Starling has received personal compensation in the range of $0-$499 for serving as a Consultant for Med-IQ. Dr. Starling has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Medscape. Dr. Starling has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Satsuma. Dr. Starling has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbvie. Dr. Starling has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Everyday Health. Dr. Starling has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Allergan. Dr. Starling has received personal compensation in the range of $500-$4,999 for serving as a Consultant for WebMD. Dr. Starling has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Miller Medical. Dr. Starling has received personal compensation in the range of $500-$4,999 for serving as a Consultant for eNeura.
Elia Sechi, MD Dr. Sechi has nothing to disclose.
Maria Alejandra Garcia-Dominguez, MD Dr. Garcia-Dominguez has nothing to disclose.
Melissa Yu, MD, FAAN An immediate family member of Dr. Yu has received personal compensation for serving as an employee of CVS/Aetna. The institution of Dr. Yu has received research support from Alzheimer's Association. The institution of Dr. Yu has received research support from Biogen. The institution of Dr. Yu has received research support from Eisai. The institution of Dr. Yu has received research support from Novo Nordisk. Dr. Yu has a non-compensated relationship as a Steering Board member with Epic Systems that is relevant to AAN interests or activities.
Olga Carmona, MD Dr. Carmona has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for MERCK. Dr. Carmona has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for BIOGEN .
Carol A. Manning, PhD The institution of Dr. Manning has received research support from Department of Defense.
Megan Behne Ms. Behne has received personal compensation for serving as an employee of The Guthy-Jackson Charitable Foundation. Ms. Behne has received personal compensation in the range of $50,000-$99,999 for serving as a Independent Contractor with The Guthy-Jackson Charitable Foundation.
Woo-jin Lee Woo-jin Lee has nothing to disclose.
Dennis W. Dickson, MD Dr. Dickson has nothing to disclose.
Sandhya Dhanjal, MD Dr. Dhanjal has nothing to disclose.
Adnan Subei, DO, FAAN Dr. Subei has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Efficient.
Diana Vargas, MD Dr. Vargas has nothing to disclose.
Sinem Seleme Ovunc, MD Dr. Ovunc has nothing to disclose.
Calli Leighann Cook, DNP, FNP-C, FAANP Dr. Cook has received personal compensation in the range of $500-$4,999 for serving as a Consultant for AbbVie. Dr. Cook has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Allergan. Dr. Cook has a non-compensated relationship as a Board Member with Alliance for Patient Access that is relevant to AAN interests or activities.
Jeffrey L. Bennett, MD, PhD, FAAN Dr. Bennett has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Horizon Therapeutics. Dr. Bennett has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Alexion. Dr. Bennett has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Genentech. Dr. Bennett has received personal compensation in the range of $500-$4,999 for serving as a Consultant for TG Therapeutics. Dr. Bennett has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Reistone Bio. Dr. Bennett has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Roche. Dr. Bennett has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Chugai. Dr. Bennett has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Mitsubishi Tanabe. Dr. Bennett has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for EMD Serono. Dr. Bennett has received personal compensation in the range of $500-$4,999 for serving as a Consultant for ImCyse. Dr. Bennett has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Beigene. Dr. Bennett has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Clene Nanomedicine. Dr. Bennett has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Bennett has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Alexion. Dr. Bennett has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Podoll. Dr. Bennett has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Patterson. The institution of Dr. Bennett has received research support from Novartis. The institution of Dr. Bennett has received research support from Alexion. Dr. Bennett has received intellectual property interests from a discovery or technology relating to health care. Dr. Bennett has received publishing royalties from a publication relating to health care.
Fernando D. Testai, MD, PhD, FAAN Dr. Testai has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier. Dr. Testai has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Swanson Martin & Bell, LLP. Dr. Testai has received publishing royalties from a publication relating to health care.
Albert Aboseif, DO Dr. Aboseif has a non-compensated relationship as a AAN Autoimmune Neurology Section -- Education Workgroup with AAN that is relevant to AAN interests or activities.
Kiley Cameron, MD Dr. Cameron has nothing to disclose.
James E. Siegler, III, MD Dr. Siegler has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Stroke: Vascular and Interventional Neurology. Dr. Siegler has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for various medicolegal cases. The institution of Dr. Siegler has received research support from Viz.ai.
Takashi Konishi, MD, PhD Dr. KONISHI has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Eisai Co., Ltd. Dr. KONISHI has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Chugai Pharmaceutical Co., Ltd..
Laura Gleeson, PhD Dr. Gleeson has nothing to disclose.
Tairine Luiza Esteves Silva, MBBS Dr. Silva has nothing to disclose.
Nicolas Sarmiento Bustamante Mr. Sarmiento Bustamante has nothing to disclose.
Bruce A. C. Cree, MD, PhD, MCR, FAAN The institution of Dr. Cree has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. The institution of Dr. Cree has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for EMD Serono. The institution of Dr. Cree has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novartis. The institution of Dr. Cree has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi. The institution of Dr. Cree has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for TG Therapeutics. The institution of Dr. Cree has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Autobahn. The institution of Dr. Cree has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Avotres. The institution of Dr. Cree has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. Dr. Cree has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Horizon. Dr. Cree has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Neuron23. Dr. Cree has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Boston Pharma. Dr. Cree has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Hexal/Sandoz. Dr. Cree has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Kyverna. Dr. Cree has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Boston Pharma. Dr. Cree has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Immunic AG. The institution of Dr. Cree has received research support from Genentech. Dr. Cree has received publishing royalties from a publication relating to health care.
James Stavropoulos James Stavropoulos has stock in Phenotips. James Stavropoulos has received intellectual property interests from a discovery or technology relating to health care.
Orhan Aktas, MD Dr. Aktas has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. Dr. Aktas has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Horizon. Dr. Aktas has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Alexion. Dr. Aktas has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. Dr. Aktas has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Horizon. Dr. Aktas has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Dr. Aktas has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sanofi. The institution of Dr. Aktas has received research support from German Research Foundation. The institution of Dr. Aktas has received research support from German Ministry of Science. The institution of Dr. Aktas has received research support from Neuromyelitis optica Study Group (NEMOS).
Eoin P. Flanagan, MBBCh, FAAN The institution of Dr. Flanagan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Flanagan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Flanagan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Horizon Therapeutics. The institution of Dr. Flanagan has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Flanagan has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Pharmacy times. The institution of Dr. Flanagan has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for UCB. The institution of Dr. Flanagan has received research support from Viela Bio. The institution of Dr. Flanagan has received research support from UCB. The institution of Dr. Flanagan has received research support from Roche. Dr. Flanagan has received publishing royalties from a publication relating to health care. Dr. Flanagan has a non-compensated relationship as a Member of medical Advisory Board with The MOG Project that is relevant to AAN interests or activities. Dr. Flanagan has a non-compensated relationship as a Editorial board member with Journal of The Neurologic Sciences that is relevant to AAN interests or activities. Dr. Flanagan has a non-compensated relationship as a Editorial board member with Neuroimmunology Reports that is relevant to AAN interests or activities. Dr. Flanagan has a non-compensated relationship as a Editorial Board Member with Neurology, Neuroimmunology Neuroinflammation (N2) Journal that is relevant to AAN interests or activities.
Carol Swetlik, MD An immediate family member of Dr. Swetlik has received personal compensation for serving as an employee of Pfizer.
Laura Andrea Pesantez Pacheco, MD Dr. Pesantez Pacheco has nothing to disclose.
Kejal Kantarci, MD The institution of Dr. Kantarci has received research support from Eli Lilly. The institution of Dr. Kantarci has received research support from NIH. The institution of Dr. Kantarci has received research support from ADDF.
Rodrigo Queiroz No disclosure on file
Timothy A. Benke, MD,PhD The institution of Dr. Benke has received research support from NIH, RSRT, IRSF and Children's Hospital Colorado. The institution of Dr. Benke has received research support from Acadia, GW, RSRT, Ovid/Takeda, Marinus. The institution of Dr. Benke has received research support from Acadia, CUREGRI, GRINtherapeutics, GW, IRSF, Marinus, Neurogene, Taysha, Ultragenyx and Zogenix/UCB; .
Mehdi Zarrei, PhD Dr. Zarrei has nothing to disclose.
Lauren Sham, MD Dr. Sham has nothing to disclose.
Betsy N. Williams, PhD Dr. Williams has received personal compensation for serving as an employee of IQVIA.
Ronit Mesterman, MD Dr. Mesterman has nothing to disclose.
Stacey Clardy, MD, PhD, FAAN Dr. Clardy has received personal compensation for serving as an employee of Veterans Health Administration (VHA). Dr. Clardy has received personal compensation for serving as an employee of University of Utah Health. Dr. Clardy has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AstraZeneca/Alexion. Dr. Clardy has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amgen/Horizon. Dr. Clardy has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Neurology/AAN Publications. The institution of Dr. Clardy has received research support from Sumaira Foundation for NMO. The institution of Dr. Clardy has received research support from NIH/NINDS. The institution of Dr. Clardy has received research support from SRNA. The institution of Dr. Clardy has received research support from Alexion/AstraZeneca. Dr. Clardy has received personal compensation in the range of $500-$4,999 for serving as a AAN Summer Meeting CoDirector Travel and Lodging with AAN. Dr. Clardy has received personal compensation in the range of $500-$4,999 for serving as a Grand Rounds Travel/Lodging/Honoraria with U of Iowa. Dr. Clardy has received personal compensation in the range of $500-$4,999 for serving as a Grand Rounds Travel/Lodging/Honoraria with Barrow Neurological Institute. Dr. Clardy has received personal compensation in the range of $500-$4,999 for serving as a Grand Rounds Travel/Lodging/Honoraria with Beaumont Health. Dr. Clardy has received personal compensation in the range of $500-$4,999 for serving as a Grand Rounds Travel/Lodging/Honoraria with Stanford. Dr. Clardy has received personal compensation in the range of $500-$4,999 for serving as a Grand Rounds Travel/Lodging/Honoraria with Cleveland Clinic.
Adam Quick, MD The institution of Dr. Quick has received research support from NINDS. The institution of Dr. Quick has received research support from NEALS.
Benjamin M. Greenberg, MD, FAAN Dr. Greenberg has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Greenberg has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. Dr. Greenberg has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for EMD Serono. Dr. Greenberg has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Horizon. Dr. Greenberg has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sanofi/Genzyme. Dr. Greenberg has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Genentech/ROche. Dr. Greenberg has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Signant. Dr. Greenberg has received personal compensation in the range of $500-$4,999 for serving as a Consultant for IQVIA. Dr. Greenberg has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sandoz. Dr. Greenberg has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bayer. Dr. Greenberg has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Clene. Dr. Greenberg has received personal compensation in the range of $500-$4,999 for serving as a Consultant for TG Therapeutics. Dr. Greenberg has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cycle Pharma. Dr. Greenberg has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for IQVIA. Dr. Greenberg has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for Siegel Rare Neuroimmune Association. Dr. Greenberg has stock in GenrAb. Dr. Greenberg has stock in Clene. The institution of Dr. Greenberg has received research support from CLENE Nanomedicine. The institution of Dr. Greenberg has received research support from Anokion. The institution of Dr. Greenberg has received research support from Regeneron. Dr. Greenberg has received intellectual property interests from a discovery or technology relating to health care. Dr. Greenberg has received publishing royalties from a publication relating to health care.
Roy E. Strowd, III, MD, FAAN Dr. Strowd has received personal compensation for serving as an employee of Kaplan. Dr. Strowd has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Monteris Medical, Inc. Dr. Strowd has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novocure. Dr. Strowd has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for American Academy of Neurology. The institution of Dr. Strowd has received research support from Southeastern Brain Tumor Foundation. The institution of Dr. Strowd has received research support from Jazz Pharmaceuticals. The institution of Dr. Strowd has received research support from National Institutes of Health. The institution of Dr. Strowd has received research support from Alpha Omega Alpha. The institution of Dr. Strowd has received research support from American Board of Psychiatry and Neurology. Dr. Strowd has received publishing royalties from a publication relating to health care. Dr. Strowd has received publishing royalties from a publication relating to health care.
Oksana Suchowersky, MD, FAAN Dr. Suchowersky has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Syneos/Alexion. The institution of Dr. Suchowersky has received research support from Roche. The institution of Dr. Suchowersky has received research support from Wave LifeSciences. The institution of Dr. Suchowersky has received research support from CHDI. Dr. Suchowersky has received publishing royalties from a publication relating to health care. Dr. Suchowersky has received publishing royalties from a publication relating to health care.
Matthew J. Barrett, MD Dr. Barrett has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Springer Healthcare LLC. The institution of Dr. Barrett has received research support from Kyowa Kirin. The institution of Dr. Barrett has received research support from NIH.
Geetanjali Singh Rathore, MD, FAAN Dr. Rathore has nothing to disclose.
Daniel Zhou, MD Dr. Zhou has nothing to disclose.
Natalie P. Witek, MD Dr. Witek has nothing to disclose.
Amy Kunchok, MBBS Dr. Kunchok has received personal compensation in the range of $0-$499 for serving as a Consultant for EMD Serono. Dr. Kunchok has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Kunchok has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Horizon therapeutics . Dr. Kunchok has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Kunchok has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Neurology.
Caroline Bittar Braune, MD Dr. Braune has nothing to disclose.
Oscar Klein Dr. Klein has nothing to disclose.
Cindy Marie Happel, RN Mrs. Happel has stock in Supernus Pharmaceutical.
Stephanie Wolff, MD Dr. Wolff has nothing to disclose.
Anna Goodheart, MD The institution of Dr. Goodheart has received research support from American Academy of Neurology.
Daniela Noa Zohar Dr. Zohar has nothing to disclose.
Michael I. Shevell, MD, FAAN Dr. Shevell has nothing to disclose.
Peter Goadsby, MD, PhD, FRS Dr. Goadsby has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Amgen. Dr. Goadsby has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Abbvie. Dr. Goadsby has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Eli-Lilly. Dr. Goadsby has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Epalex. Dr. Goadsby has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novartis. Dr. Goadsby has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Teva Pharmaceuticals. Dr. Goadsby has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Praxis. Dr. Goadsby has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Lundbeck. Dr. Goadsby has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Satsuma. Dr. Goadsby has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Pfizer. Dr. Goadsby has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi. Dr. Goadsby has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Shiratronics. Dr. Goadsby has received personal compensation in the range of $500-$4,999 for serving as a Consultant for CoolTech LLC. Dr. Goadsby has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Linpharma. Dr. Goadsby has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Tremeau. Dr. Goadsby has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Dr Reddys. Dr. Goadsby has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Aeon Biopharma. Dr. Goadsby has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Massachusetts Medical Society. The institution of Dr. Goadsby has received research support from Celgene. The institution of Dr. Goadsby has received research support from NIHR. The institution of Dr. Goadsby has received research support from Kallyope. Dr. Goadsby has received publishing royalties from a publication relating to health care. Dr. Goadsby has received publishing royalties from a publication relating to health care. Dr. Goadsby has a non-compensated relationship as a Trustee with Migraine Trust that is relevant to AAN interests or activities. Dr. Goadsby has a non-compensated relationship as a Trustee with Organisation for Understanding Cluster Headache (UK) that is relevant to AAN interests or activities. Dr. Goadsby has a non-compensated relationship as a Executive roles with American Headache Society that is relevant to AAN interests or activities. Dr. Goadsby has a non-compensated relationship as a Director with American Migraine Foundation that is relevant to AAN interests or activities.
Alfonso Sebastian Lopez, MD Dr. Lopez has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Horizon. Dr. Lopez has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech .
Mark Hallett, MD, FAAN Dr. Hallett has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen. Dr. Hallett has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Brainsway. Dr. Hallett has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for VoxNeuro. Dr. Hallett has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for QuantalX. Dr. Hallett has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier. Dr. Hallett has received intellectual property interests from a discovery or technology relating to health care. Dr. Hallett has received publishing royalties from a publication relating to health care. Dr. Hallett has received publishing royalties from a publication relating to health care. Dr. Hallett has received publishing royalties from a publication relating to health care. Dr. Hallett has received publishing royalties from a publication relating to health care. Dr. Hallett has received personal compensation in the range of $500-$4,999 for serving as a Speaker with International Parkinson and Movement Disorder Society. Dr. Hallett has a non-compensated relationship as a President, Past-president with International Federation of Clinical Neurophysiology that is relevant to AAN interests or activities. Dr. Hallett has a non-compensated relationship as a President, Past-President with Functional Neurological Disorder Society that is relevant to AAN interests or activities.
Zubair Ahmed, MD Dr. Ahmed has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Eli Lilly. Dr. Ahmed has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Abbvie. Dr. Ahmed has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biohaven.
Mary Alissa Willis, MD, FAAN Dr. Willis has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Alexion, Biogen. Dr. Willis has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Alexion, Biogen.
Amy B. Sullivan, PhD Dr. Sullivan has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novartis. Dr. Sullivan has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bristol-Myers Squibb. Dr. Sullivan has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Sullivan has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech. Dr. Sullivan has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Serono. Dr. Sullivan has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi.
Jonathan Graff-Radford, MD, FAAN Dr. Graff-Radford has received personal compensation for serving as an employee of Mayo Clinic. Dr. Graff-Radford has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for NINDS/NIH. Dr. Graff-Radford has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for American Academy of Neurology. The institution of Dr. Graff-Radford has received research support from NIH. The institution of Dr. Graff-Radford has received research support from Eisai.
David S. Knopman, MD, FAAN Dr. Knopman has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for DIAN TU study. The institution of Dr. Knopman has received research support from NIH.
Ulrike Kaunzner, MD Dr. Kaunzner has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Kaunzner has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Medlearning.
Joseph Ryan Geraghty Mr. Geraghty has received publishing royalties from a publication relating to health care.
Maryam Oskoui, MD, FAAN Dr. Oskoui has received personal compensation in the range of $500-$4,999 for serving as an officer or member of the Board of Directors for the Association des Neurologues du Quebec. The institution of Dr. Oskoui has received research support from Biogen. The institution of Dr. Oskoui has received research support from Roche Genetech. The institution of Dr. Oskoui has received research support from Muscular Dystrophy Canada. The institution of Dr. Oskoui has received research support from Canadian Institutes of Health Research. Dr. Oskoui has a non-compensated relationship as a Member of the Medical and Scientific Advisory Committee with Muscular Dystrophy Canada that is relevant to AAN interests or activities. Dr. Oskoui has a non-compensated relationship as a Member of the External Advisory Board with MDUK Oxford Neuromuscular Centre that is relevant to AAN interests or activities.
Yoji Hoshina, MD Dr. Hoshina has nothing to disclose.
Oren Meyers, PhD Dr. Meyers has received personal compensation for serving as an employee of IQVIA.
Christina Graham Ms. Graham has received personal compensation for serving as an employee of IQVIA.
P Ganesh, MBBS No disclosure on file
Jonathan Ross Galli, MD Dr. Galli has nothing to disclose.
Bradley F. Boeve, MD, FAAN Dr. Boeve has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for Rainwater Charitable Foundation. The institution of Dr. Boeve has received research support from Alector. The institution of Dr. Boeve has received research support from GE Healthcare. The institution of Dr. Boeve has received research support from Transposon. The institution of Dr. Boeve has received research support from Cognition Therapeutics. Dr. Boeve has received publishing royalties from a publication relating to health care.
Amanda Lee Piquet, MD, FAAN The institution of Dr. Piquet has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Genentech. The institution of Dr. Piquet has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Alexion. The institution of Dr. Piquet has received personal compensation in the range of $0-$499 for serving as a Consultant for UCB. The institution of Dr. Piquet has received personal compensation in the range of $0-$499 for serving as a Consultant for EMD Serono. Dr. Piquet has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Piquet has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. The institution of Dr. Piquet has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Piquet has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Sands Anderson PC. Dr. Piquet has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Joe Jones Law Firm. The institution of Dr. Piquet has received research support from Rocky Mountain MS Center. The institution of Dr. Piquet has received research support from Novartis. The institution of Dr. Piquet has received research support from Abbvie. The institution of Dr. Piquet has received research support from Roche/Genentech. The institution of Dr. Piquet has received research support from NYU. The institution of Dr. Piquet has received research support from Anokion. The institution of Dr. Piquet has received research support from UCB . The institution of Dr. Piquet has received research support from Foundation for Sarcoidosis. Dr. Piquet has received publishing royalties from a publication relating to health care. Dr. Piquet has received publishing royalties from a publication relating to health care. Dr. Piquet has received personal compensation in the range of $10,000-$49,999 for serving as a Litigative Consultant with US-Dept HHS/DICP. Dr. Piquet has a non-compensated relationship as a Medical Advisory Board Member with Autoimmune Encephalitis Alliance (AEA) that is relevant to AAN interests or activities. Dr. Piquet has a non-compensated relationship as a Medical Advisory Board Member with Stiff Person Syndrome Research Foundation (SPSRF) that is relevant to AAN interests or activities.
Ruple S. Laughlin, MD, FAAN Dr. Laughlin has nothing to disclose.
David T. Jones, MD Dr. Jones has nothing to disclose.
Neill R. Graff-Radford, MD, FAAN The institution of Dr. Graff-Radford has received research support from Biogen. The institution of Dr. Graff-Radford has received research support from Lilly. The institution of Dr. Graff-Radford has received research support from Novartis. The institution of Dr. Graff-Radford has received research support from AbbVie. Dr. Graff-Radford has received publishing royalties from a publication relating to health care.
James F. Rini, MD Dr. Rini has a non-compensated relationship as a Member on Advisory Board with Lilly that is relevant to AAN interests or activities.
Christina Caon, BS, RN Ms. Caon has received personal compensation for serving as an employee of EMD Serono.
Stephen Forrest Trudeau, MD Dr. Trudeau has nothing to disclose.
Silvia Basaia Silvia Basaia has nothing to disclose.
Robert A. Bermel, MD Dr. Bermel has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Bermel has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi/Genzyme. Dr. Bermel has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Genentech/Roche. Dr. Bermel has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Viela Bio. Dr. Bermel has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis. Dr. Bermel has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Merck Serono. Dr. Bermel has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Astra Zeneca. Dr. Bermel has received personal compensation in the range of $500-$4,999 for serving as a Consultant for LabCorp. Dr. Bermel has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for TG Therapeutics. The institution of Dr. Bermel has received research support from Biogen. The institution of Dr. Bermel has received research support from Roche. The institution of Dr. Bermel has received research support from Novartis. Dr. Bermel has received intellectual property interests from a discovery or technology relating to health care.
Donald Grosset Donald Grosset has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Glasgow Memory Clinic. Donald Grosset has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for IQVIA. Donald Grosset has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for AbbVie. Donald Grosset has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Britannia. Donald Grosset has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for GE Healthcare. The institution of Donald Grosset has received research support from Parkinson's UK. Donald Grosset has received personal compensation in the range of $10,000-$49,999 for serving as a Clinical Director Excellence Network with Parkinson's UK.
Luisa Hildegard Klotz, MD Dr. Klotz has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bayer. Dr. Klotz has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. Dr. Klotz has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Genzyme. Dr. Klotz has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Bristol Myers Squibb. Dr. Klotz has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Merck Serono. Dr. Klotz has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novartis. Dr. Klotz has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Teva. Dr. Klotz has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Klotz has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Klotz has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Klotz has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Klotz has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Dr. Klotz has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Klotz has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Horizon. Dr. Klotz has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Viatris. Dr. Klotz has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for BMS. The institution of Dr. Klotz has received research support from Immunic AG. The institution of Dr. Klotz has received research support from Merck.
Jonathan Perk, MD, PhD, FAAN Dr. Perk has nothing to disclose.
Derrick Robertson, MD Dr. Robertson has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Alexion. Dr. Robertson has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biogen. Dr. Robertson has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Bristol Myers Squibb. Dr. Robertson has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for EMD Serono. Dr. Robertson has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Genentech. Dr. Robertson has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Greenwich Biosciences. Dr. Robertson has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Horizon. Dr. Robertson has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Janssen. Dr. Robertson has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novartis. Dr. Robertson has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sanofi Genzyme. Dr. Robertson has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for TG Therapeutics. Dr. Robertson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Mallinckrodt. Dr. Robertson has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Alexion. Dr. Robertson has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Biogen. Dr. Robertson has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Bristol Myers Squibb. Dr. Robertson has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for EMD Serono. Dr. Robertson has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Genentech. Dr. Robertson has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Sanofi Genzyme. Dr. Robertson has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for PRIME CME. Dr. Robertson has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Janssen. Dr. Robertson has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Horizon. Dr. Robertson has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for TG Therapeutics. Dr. Robertson has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for McVeigh. Dr. Robertson has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Mccumber. Dr. Robertson has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Goodis. The institution of Dr. Robertson has received research support from Biogen. The institution of Dr. Robertson has received research support from EMD Serono. The institution of Dr. Robertson has received research support from Jansenn. The institution of Dr. Robertson has received research support from Genentech. The institution of Dr. Robertson has received research support from Patient-Centered Outcomes Research Institute. The institution of Dr. Robertson has received research support from Novartis. The institution of Dr. Robertson has received research support from Sanofi Genzyme. The institution of Dr. Robertson has received research support from TG Therapeutics. The institution of Dr. Robertson has received research support from Prime. The institution of Dr. Robertson has received research support from Greenwich Biosciences. The institution of Dr. Robertson has received research support from Atara Biotherapeutics. The institution of Dr. Robertson has received research support from CorEvitas. The institution of Dr. Robertson has received research support from Anokion. Dr. Robertson has received personal compensation in the range of $500-$4,999 for serving as a Speaker with Consortium of Multiple Sclerosis Centers. Dr. Robertson has received personal compensation in the range of $500-$4,999 for serving as a Speaker with Multiple Sclerosis Association of America.
Nadia Azad Ms. Azad has nothing to disclose.
Alisa Mo, MD, PhD Dr. Mo has nothing to disclose.
Changning Wang, PhD Dr. Wang has nothing to disclose.
Harry Zobel, Jr., DO Dr. Zobel has nothing to disclose.
Sudipa Biswas, MD Dr. Biswas has nothing to disclose.
Eliana Marisa Ramos The institution of Eliana Marisa Ramos has received research support from NIH.
Jeffrey Neul, MD, PhD Dr. Neul has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Acadia. Dr. Neul has received personal compensation in the range of $500-$4,999 for serving as a Consultant for GW Pharmaceuticals. Dr. Neul has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Signant Health. Dr. Neul has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Analysis Group. Dr. Neul has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Taysha Gene Therapies. Dr. Neul has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alcyone. Dr. Neul has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Ovid. Dr. Neul has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Neul has stock in LizardBio. The institution of Dr. Neul has received research support from NIH. The institution of Dr. Neul has received research support from Acadia. The institution of Dr. Neul has received research support from GW Pharmaceuticals. The institution of Dr. Neul has received research support from International Rett Syndrome Foundation. The institution of Dr. Neul has received research support from Rett Syndrome Research Trust.
Monica Hall, MD Dr. Hall has nothing to disclose.
Bahadar Singh Srichawla, DO, MS Dr. Srichawla has nothing to disclose.
Serena Spudich, MD The institution of Dr. Spudich has received research support from NIH.
Kelsey Stefan, MD Ms. Stefan has nothing to disclose.
Laura Danielson, MD Dr. Danielson has nothing to disclose.
Takashi Matsudaira, MD,PhD The institution of Dr. Matsudaira has received research support from Sumitomo Pharma Co., Ltd. .
Lindsey Michael Ladd, DO Dr. Ladd has nothing to disclose.
Kathryn E. Cheponis, MD Dr. Ess has nothing to disclose.
David Pettersson David Pettersson has nothing to disclose.
Robert H. Paul Robert H. Paul has nothing to disclose.
Jacqueline French, MD, FAAN Dr. French has received personal compensation in the range of $50,000-$99,999 for serving as an officer or member of the Board of Directors for Epilepsy Foundation. The institution of Dr. French has received research support from Epilepsy Study Consortium/ Epilepsy Foundation (Funded by UCB). The institution of Dr. French has received research support from GW/One8 Foundation/FACES. The institution of Dr. French has received research support from NINDS. The institution of Dr. French has received research support from Xenon. The institution of Dr. French has received research support from Cerevel. The institution of Dr. French has received research support from FACES. The institution of Dr. French has received research support from UCB. The institution of Dr. French has received research support from Epilepsy Study Consortium. The institution of Dr. French has received research support from UCB. Dr. French has received personal compensation in the range of $100,000-$499,999 for serving as a Chief Medical/Innovation Officer with Epilepsy Foundation. Dr. French has a non-compensated relationship as a Consultant with Angelini that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a consultant with Alterity Therapeutics Limited that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a consultant with Bright minds Biosciences that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Cerecin Inc that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Cognizance Biomarkers that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Arvelle that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a consultant with Beacon biosignals that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant, Advisory Board with Biohaven Pharmaceuticals that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Bloom Science Inc that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with BridgeBio Pharma Inc that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a consultant, scientific advisory board with Camp4 Therapeutics Corporation that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant, Scientific Advisory Board with Cerebral Therapeutics that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Cerevel that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a SAB with Coda Biotherapeutics that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Genentech Inc that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Crossject that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Eisai, that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Eliem Therapeutics that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Encoded Therapeutics that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with iQure Pharma that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant, SAB with Engrail that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a SAB with Epihunter that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a SAB with Epiminder that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Epitel Inc that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Equilibre BioPharmaceuticals that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a consultant with Greenwich Biosciences that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Grin Therapeutics that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with GW Pharma that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Janssen Pharmaceutica that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a consultant with Jazz Pharmaceuticals that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Knopp Biosciences that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Lipocine that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with LivaNova that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Longboard Pharmaceuticals that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant, SAB with Lundbeck that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant, SAB with Marinus that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a consultant with Modulight Bio that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Leal therapeutics that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Neumirna Therapeutics that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant,SAB with Neurocrine that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Neuroelectrics USA Corporation that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Neuronetics Inc that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Ono Pharmaceutical Co that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant, SAB with Otsuka Pharmaceutical Development that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant, SAB with Ovid Therapeutics Inc that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Paladin Labs Inc that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Rapport Therapeutics that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Praxis that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with PureTech LTY Inc that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a consultant with SK Life Sciences that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Stoke that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Supernus that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a consultant with Takeda that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant, SAB with UCB Inc that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Ventus Therapeutics that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a consulting, steering committee with Xenon that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a consultant with Korro Bio Inc that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with NeuroPro Therapeutics that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Advisory board with Receptor that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Advisory board with Sage Therpeutics that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Advisory Board with Third Rock Ventures that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Vida Ventures Management that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consulting with Pfizer that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consulting with Agrithera, Inc that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a consulting with Autifony therapeutics, Unlimited that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consulting with Baergic Bio that is relevant to AAN interests or activities.
Stephen Neil Gomperts, MD, PhD Dr. Gomperts has received personal compensation in the range of $500-$4,999 for serving as a Consultant for EIP. Dr. Gomperts has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cowen. Dr. Gomperts has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bob's Last Stand. Dr. Gomperts has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Focus Boston. Dr. Gomperts has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Expert connect. Dr. Gomperts has received personal compensation in the range of $0-$499 for serving as a Consultant for Mosaic. Dr. Gomperts has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Jannsen. The institution of Dr. Gomperts has received research support from NIH. The institution of Dr. Gomperts has received research support from LBDA. The institution of Dr. Gomperts has received research support from DOD/CDMRP. The institution of Dr. Gomperts has received research support from FFFPRI. The institution of Dr. Gomperts has received research support from NIH. The institution of Dr. Gomperts has received research support from MJFF. The institution of Dr. Gomperts has received research support from NIH. The institution of Dr. Gomperts has received research support from NIH. The institution of Dr. Gomperts has received research support from MJFF. The institution of Dr. Gomperts has received research support from NIH. The institution of Dr. Gomperts has received research support from NIH. Dr. Gomperts has received intellectual property interests from a discovery or technology relating to health care.
Friedemann Paul The institution of Dr. Paul has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Mitsubishi Tanabe PC (MTPC). The institution of Dr. Paul has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Aarhus University. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Paul has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi Genzyme. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB Pharma. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for CELGENE. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Bayer. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for ACRELION. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Viela Bio. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alexion. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Pfizter. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Merck Serono. The institution of Dr. Paul has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Springer.
Amna Ramzan, MD, MBBS Dr. Ramzan has nothing to disclose.
Scott Speelziek, MD Dr. Speelziek has nothing to disclose.
Maria Petracca, PhD Dr. Petracca has nothing to disclose.
Moriah Mabry Ms. Mabry has nothing to disclose.
Elisabetta Pagani Elisabetta Pagani has nothing to disclose.
Tomokazu Obi, MD Dr. Obi has nothing to disclose.
Huma Nawaz, MBBS Dr. Nawaz has nothing to disclose.
Edward Higginbotham, Other Mr. Higginbotham has nothing to disclose.
Rachel Galioto Rachel Galioto has nothing to disclose.
Adam Wayne Nowlan, MD Dr. Nowlan has received personal compensation for serving as an employee of GT Medical. Dr. Nowlan has received personal compensation in the range of $500-$4,999 for serving as a Consultant for GT Medical.
Robin Ryther, MD, PhD The institution of Dr. Ryther has received research support from Acadia.
Dawa Samdup, MD Dr. Samdup has nothing to disclose.
Lucía *use 253857 Forero Lucía Forero has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Lucía Forero has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Roche .
Iyad Alnahhas, MD The institution of Dr. Alnahhas has received research support from Novocure.
Kristen Fisher, DO Dr. Fisher has nothing to disclose.
Osman Ozel, MD Dr. Ozel has nothing to disclose.
Jenna Gentile Jenna Gentile has nothing to disclose.
Elisa Canu The institution of Elisa Canu has received research support from Italian Ministry of Health .
Carlo Sacdalan, MD Dr. Sacdalan has nothing to disclose.
Jun Tae Park, MD Dr. Park has nothing to disclose.
Nele Retzlaff, Other Mrs. Retzlaff has nothing to disclose.
Paulus Stefan Rommer Dr. Rommer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. Dr. Rommer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Rommer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for biogen. The institution of Dr. Rommer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for celgene. The institution of Dr. Rommer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for merck. Dr. Rommer has received personal compensation in the range of $0-$499 for serving as a Consultant for sanofi. Dr. Rommer has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for sandoz. Dr. Rommer has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Abbvie. Dr. Rommer has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for almirall. Dr. Rommer has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for biogen. Dr. Rommer has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Dr. Rommer has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Merck. The institution of Dr. Rommer has received research support from merck. The institution of Dr. Rommer has received research support from roche. The institution of Dr. Rommer has received research support from amicus. The institution of Dr. Rommer has received research support from biogen.
Helena Groot Helena Groot, 9922 has nothing to disclose.
Donald Joseph Langan, Jr., MD Dr. Langan has nothing to disclose.
Ryan Yuen Ryan Yuen has nothing to disclose.
Jennifer Marie Martinez-Thompson, MD Dr. Martinez-Thompson has nothing to disclose.
David Eyerman David Eyerman has received personal compensation for serving as an employee of Apellis Pharmaceuticals . David Eyerman has stock in Apellis Pharmaceuticals . David Eyerman has stock in Fulcrum Therapeutics . David Eyerman has stock in Alkermes . David Eyerman has stock in Denali Therapeutics. David Eyerman has stock in Beam Therapeutics. David Eyerman has stock in Passage Bio .
Federica Agosta Federica Agosta has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Philips. Federica Agosta has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier INC.
Qais A. Samara No disclosure on file
Ignacio Mata Ignacio Mata has nothing to disclose.
Jaime Toro, MD, FAAN Dr. Toro has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Watch Neurology .
Gaelle Klingelschmitt Gaelle Klingelschmitt has received personal compensation for serving as an employee of F.Hoffmann-La Roche LTD.
Maria Lapid The institution of Maria Lapid has received research support from NIA.
Danielle Spengler Shpiner, MD An immediate family member of Dr. Shpiner has received personal compensation for serving as an employee of University of Miami.
Cisem Cinar, MD Dr. Cinar has nothing to disclose.
Keionna Brown, NP Mrs. Brown has nothing to disclose.
Fen Bao Fen Bao has nothing to disclose.
Angela Lunde, Other Ms. Lunde has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Mayo Clinic .
David Felipe Cuellar Giraldo, Jr., MD Dr. Cuellar Giraldo has nothing to disclose.
Alan M. Rapoport, MD, FAAN Dr. Rapoport has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for AbbVie, Amgen, Biohaven, Cala Health, Satsuma, Teva Pharmaceutical Industries, Theranica, Xoc and Zosano. Dr. Rapoport has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for AbbVie, Amgen, Biohaven, Lundbeck and Teva Pharmaceutical Industries. Dr. Rapoport has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Neurology Reviews.
Erika Sigman, MD Dr. Sigman has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Journal of Clinical Neuroscience.
Ricardo Alonso Ricardo Alonso has nothing to disclose.
Florencia Micaela Daniele Miss Daniele has nothing to disclose.
Leah Kathleen Forsberg, PhD Ms. Forsberg has nothing to disclose.
Julia Klein, NP An immediate family member of Ms. Klein has received personal compensation for serving as an employee of Amgen. An immediate family member of Ms. Klein has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Amgen.
Amanda Jones Ms. Jones has received personal compensation for serving as an employee of Axsome Therapeutics. Ms. Jones has received stock or an ownership interest from Axsome Therapeutics.
Alice D. Lam, MD Dr. Lam has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sage Therapeutics. Dr. Lam has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neurona Therapeutics. Dr. Lam has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Cognito Therapeutics. The institution of Dr. Lam has received research support from Sage Therapeutics.
Daniele Merico, PhD Dr. Merico has received personal compensation for serving as an employee of Deep Genomics. Dr. Merico has stock in Deep Genomics.
Prashant Natteru, MBBS Dr. Natteru has nothing to disclose.
Ryane Adams Miss Adams has nothing to disclose.
Thomas Finnegan, Jr., PhD Dr. Finnegan has nothing to disclose.
Vivek Shukla, MD Dr. Shukla has nothing to disclose.
Christine Considine Christine Considine has nothing to disclose.
Marcello Moccia Marcello Moccia, 2019 has nothing to disclose.
Eungseok Oh, MD, PhD Prof. Oh has nothing to disclose.
Mirjam Korporal-Kuhnke, MD Dr. Korporal-Kuhnke has nothing to disclose.
Juan Sebastian Rivera Perez, MD Dr. Rivera Perez has nothing to disclose.
Kayla Martin, MD Dr. Martin has received research support from Tartar Trust. The institution of Dr. Martin has received research support from OHSU Foundation.
Massimo Filippi, MD, FAAN Dr. Filippi has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Alexion, Almirall, Biogen, Merck, Novartis, Roche, Sanofi;. Dr. Filippi has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion, Biogen, Bristol-Myers Squibb, Merck, Novartis, Roche, Sanofi, Sanofi-Aventis, Sanofi- Genzyme, Takeda. Dr. Filippi has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Bayer, Biogen, Celgene, Chiesi Italia SpA, Eli Lilly, Genzyme, Janssen, Merck-Serono, Neopharmed Gentili, Novartis, Novo Nordisk, Roche, Sanofi, Takeda, and TEVA. Dr. Filippi has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Springer Nature. The institution of Dr. Filippi has received research support from Biogen Idec, Merck-Serono, Novartis, Roche, the Italian Ministry of Health, the Italian Ministry of University and Research, and Fondazione Italiana Sclerosi Multipla.
Tatsuhiro Terada, MD,PhD Dr. Terada has nothing to disclose.
Milena Lobaina, MD Dr. Lobaina has nothing to disclose.
William Rees William Rees has received personal compensation for serving as an employee of Horizon Therapeutics. William Rees has received personal compensation for serving as an employee of Viela Bio. William Rees has received stock or an ownership interest from Horizon Therapeutics. William Rees has received stock or an ownership interest from Viela Bio. William Rees has received intellectual property interests from a discovery or technology relating to health care. William Rees has received intellectual property interests from a discovery or technology relating to health care.
Roberto Rodriguez, MD Dr. Rodriguez has nothing to disclose.
Sadaf Iftikhar, MBBS Dr. Iftikhar has nothing to disclose.
Eric Pappert Eric Pappert has received personal compensation for serving as an employee of Sunovion Pharmaceuticals Inc..
Elijah W Hale Mr. Hale has nothing to disclose.
Susanne Awad, PhD Dr. Awad has nothing to disclose.
Anna C. Sullivan No disclosure on file
Katie Ann Dunleavy, MD Dr. Dunleavy has nothing to disclose.
Alen Delic Alen Delic has nothing to disclose.
Jerome De Seze Jerome De Seze has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Pharma. Jerome De Seze has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Pharma. Jerome De Seze has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Pharma. Jerome De Seze has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Pharma. Jerome De Seze has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Pharma. Jerome De Seze has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Pharma. Jerome De Seze has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Pharma. Jerome De Seze has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Pharma.
Monisha Goyal, MD Dr. Goyal has nothing to disclose.
Shravan Sivakumar, MBBS Dr. Sivakumar has nothing to disclose.
Catherine Jordan Miss Jordan has nothing to disclose.
Rajesh Pahwa, MD, FAAN Dr. Pahwa has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Abbott. Dr. Pahwa has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for AbbVie. Dr. Pahwa has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for ACADIA. Dr. Pahwa has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Acorda. Dr. Pahwa has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Amneal. Dr. Pahwa has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Cala Health. Dr. Pahwa has received personal compensation in the range of $0-$499 for serving as a Consultant for Global Kinetics. Dr. Pahwa has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Kyowa. Dr. Pahwa has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Lundbeck. Dr. Pahwa has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neurocrine. Dr. Pahwa has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sunovion. Dr. Pahwa has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Supernus. Dr. Pahwa has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Allevion. Dr. Pahwa has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Avion. Dr. Pahwa has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Insightec. Dr. Pahwa has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Jaaz. Dr. Pahwa has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Neuroderm. Dr. Pahwa has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Photopharmics. Dr. Pahwa has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sage. Dr. Pahwa has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Wren. The institution of Dr. Pahwa has received research support from Abbott. The institution of Dr. Pahwa has received research support from Abbvie. The institution of Dr. Pahwa has received research support from Biogen. The institution of Dr. Pahwa has received research support from Biohaven. The institution of Dr. Pahwa has received research support from Boston Scientific. The institution of Dr. Pahwa has received research support from EIP. The institution of Dr. Pahwa has received research support from Global Kinetics. The institution of Dr. Pahwa has received research support from Amneal. The institution of Dr. Pahwa has received research support from Neuraly. The institution of Dr. Pahwa has received research support from Parkinson Foundation. The institution of Dr. Pahwa has received research support from Pharma 2B. The institution of Dr. Pahwa has received research support from Roche. The institution of Dr. Pahwa has received research support from Sage. The institution of Dr. Pahwa has received research support from Sun Pharma. The institution of Dr. Pahwa has received research support from Theranexus. The institution of Dr. Pahwa has received research support from Theravance. The institution of Dr. Pahwa has received research support from Voyager. The institution of Dr. Pahwa has received research support from Neuroderm.
Lauren DiSalvo, DO Dr. DiSalvo has nothing to disclose.
Martin W. Hümmert, MD Dr. Hümmert has nothing to disclose.
Richard Wintle, PhD Dr. Wintle has nothing to disclose.
Ilya Ayzenberg Dr. Ayzenberg has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Ayzenberg has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Dr. Ayzenberg has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi Aventis. Dr. Ayzenberg has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Ayzenberg has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Horizon. Dr. Ayzenberg has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alexion. Dr. Ayzenberg has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. Dr. Ayzenberg has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Merck. The institution of Dr. Ayzenberg has received research support from Diamed.
Janice Pieretti, MD Dr. Pieretti has nothing to disclose.
Nittaya Phanuphak The institution of Nittaya Phanuphak has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for ViiV Healthcare. The institution of Nittaya Phanuphak has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Gilead Sciences. The institution of Nittaya Phanuphak has received research support from Gilead Sciences. The institution of Nittaya Phanuphak has received research support from USAID. The institution of Nittaya Phanuphak has received research support from IAPAC.
Dana Alyse Sugar, MD Dr. Sugar has nothing to disclose.
Hugo Botha, MD Dr. Botha has received research support from NIH.
Maria Campo Amigo Maria Campo Amigo has nothing to disclose.
Renpei Sengoku, MD Dr. Sengoku has nothing to disclose.
Spiros Blackburn Spiros Blackburn has nothing to disclose.
Kathryn Dusenbery Kathryn Dusenbery has nothing to disclose.
Kaitlin Christine Smith, Other Ms. Smith has nothing to disclose.
William R. Tyor, MD, FAAN The institution of Dr. Tyor has received research support from NIH. The institution of Dr. Tyor has received research support from VHA. The institution of Dr. Tyor has received research support from NIH. The institution of Dr. Tyor has received research support from VHA. The institution of Dr. Tyor has received research support from NIH.
Erick Hauck No disclosure on file
Camille Merhi, MD Dr. Merhi has nothing to disclose.
Heitor Cabral Frade, MD Dr. Cabral Frade has nothing to disclose.
Stacy S. Wu, MD Dr. Wu has received personal compensation for serving as an employee of Sunovion Pharmaceuticals Inc. Dr. Wu has stock in Novartis.
Ana Belen Caminero Rodriguez, MD Dr. Caminero Rodriguez has nothing to disclose.
Ilana B. Katz Sand, MD The institution of Dr. Katz Sand has received research support from National Multiple Sclerosis Society. The institution of Dr. Katz Sand has received research support from Hirschl Foundation. The institution of Dr. Katz Sand has received research support from National Institutes of Health. Dr. Katz Sand has received personal compensation in the range of $500-$4,999 for serving as a Conference presenter with American Academy of Neurology.
Laura J. Wu, MD, PhD Dr. Wu has nothing to disclose.
David W. Dodick, MD, FAAN Dr. Dodick has received personal compensation for serving as an employee of Mayo Clinic. Dr. Dodick has received personal compensation for serving as an employee of Atria Health. Dr. Dodick has received personal compensation for serving as an employee of Thomas Jefferson University . Dr. Dodick has received personal compensation for serving as an employee of Norwegian University of Science and Technology. Dr. Dodick has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Amgen. Dr. Dodick has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Allergan. Dr. Dodick has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Abbvie. Dr. Dodick has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biohaven. Dr. Dodick has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biopharm Communications. Dr. Dodick has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Lundbeck. Dr. Dodick has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Eli Lilly. Dr. Dodick has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Teva. Dr. Dodick has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Inside Practice Australia. Dr. Dodick has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Clinical Education Alliance. Dr. Dodick has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Genentech. Dr. Dodick has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Headache Cooperative of the Pacific . Dr. Dodick has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Medica Communications. Dr. Dodick has received personal compensation in the range of $500-$4,999 for serving as a Consultant for MJ Healthcare. Dr. Dodick has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Nocira. Dr. Dodick has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Praxis. Dr. Dodick has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Revance . Dr. Dodick has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Synapse Medical Communications. Dr. Dodick has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Vector Psychometrics. Dr. Dodick has received personal compensation in the range of $0-$499 for serving as a Consultant for Ayya Biosciences. Dr. Dodick has received personal compensation in the range of $0-$499 for serving as a Consultant for Theranica. Dr. Dodick has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Atria. Dr. Dodick has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for WebMD. Dr. Dodick has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Thomas Jefferson University. Dr. Dodick has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Medforce. Dr. Dodick has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Precision HEOR. Dr. Dodick has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Genentech. Dr. Dodick has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Canadian Headache Society. Dr. Dodick has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Headache Cooperative of New England. Dr. Dodick has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Amgen Japan. Dr. Dodick has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for KingDevick Technologies. Dr. Dodick has received personal compensation in the range of $1,000,000+ for serving as an officer or member of the Board of Directors for Precon Health. Dr. Dodick has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for Ontologics. Dr. Dodick has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for Matterhorn. Dr. Dodick has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for Axon Therapeutics. Dr. Dodick has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for Cephalgia Group. Dr. Dodick has stock in Healint. Dr. Dodick has stock in Theranica. Dr. Dodick has stock in Aural Analytics . Dr. Dodick has stock in Epien. Dr. Dodick has stock in Matterhorn. Dr. Dodick has stock in Ontologics. Dr. Dodick has stock in Precon Health. Dr. Dodick has stock in King Devick Technologies. Dr. Dodick has stock in Nocira. Dr. Dodick has stock in Exsano. Dr. Dodick has stock in Palion. Dr. Dodick has stock in AYYA Biosciences. Dr. Dodick has stock in Perfood. Dr. Dodick has stock in Cephalgia Group. Dr. Dodick has stock in Atria Health. Dr. Dodick has stock in Man and Science. Dr. Dodick has stock in Eigenlyfe. An immediate family member of Dr. Dodick has stock in ScotiaLyfe. Dr. Dodick has stock in Axon Therapeutics. The institution of Dr. Dodick has received research support from Department of Defense. The institution of Dr. Dodick has received research support from Patient Centered Outcomes Research Institute. The institution of Dr. Dodick has received research support from Henry Jackson Foundation. Dr. Dodick has received intellectual property interests from a discovery or technology relating to health care. Dr. Dodick has received intellectual property interests from a discovery or technology relating to health care. Dr. Dodick has received intellectual property interests from a discovery or technology relating to health care. Dr. Dodick has received publishing royalties from a publication relating to health care. Dr. Dodick has received publishing royalties from a publication relating to health care. Dr. Dodick has received publishing royalties from a publication relating to health care. Dr. Dodick has a non-compensated relationship as a Chair with American Brain Foundation that is relevant to AAN interests or activities. Dr. Dodick has a non-compensated relationship as a Committee member/Course Director with American Academy of Neurology that is relevant to AAN interests or activities. Dr. Dodick has a non-compensated relationship as a Chair/Immediate Past Chair with American Migraine Foundation that is relevant to AAN interests or activities. Dr. Dodick has a non-compensated relationship as a Chair Global Patient Advocacy Coalition with International Headache Society that is relevant to AAN interests or activities.
Alfonso Fasano, MD, PhD, FAAN Dr. Fasano has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Abbott. Dr. Fasano has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Abbvie. Dr. Fasano has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ipsen. Dr. Fasano has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Medtronic. Dr. Fasano has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Boston Scientific. Dr. Fasano has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abbott. Dr. Fasano has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Medtronic. Dr. Fasano has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Ceregate. Dr. Fasano has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Inbrain Neuroelectronics. Dr. Fasano has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Syneos Health. Dr. Fasano has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Annovis. Dr. Fasano has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for CADTH. The institution of Dr. Fasano has received research support from Boston Scientific. The institution of Dr. Fasano has received research support from Medtronic. The institution of Dr. Fasano has received research support from Abbvie. Dr. Fasano has received publishing royalties from a publication relating to health care.
Mary R. Rensel, MD, FAAN Dr. Rensel has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. Dr. Rensel has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cycle Pharma. Dr. Rensel has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for biogen. Dr. Rensel has stock in Brain Ops Group LLC. Dr. Rensel has stock in Brain Fresh LLC . The institution of Dr. Rensel has received research support from NMSS. The institution of Dr. Rensel has received research support from Biogen. The institution of Dr. Rensel has received research support from genentech. The institution of Dr. Rensel has received research support from Roche- Genentech .
Chafic Y. Karam, MD Dr. Karam has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Alnylam. Dr. Karam has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ionis. Dr. Karam has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi. Dr. Karam has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Argenx. Dr. Karam has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. Dr. Karam has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Neuroderm.
Marisa P. McGinley, DO Dr. McGinley has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Octave. Dr. McGinley has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. McGinley has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for EMD Serono. The institution of Dr. McGinley has received research support from Novartis. The institution of Dr. McGinley has received research support from Biogen. The institution of Dr. McGinley has received research support from Genentech. The institution of Dr. McGinley has received research support from NIH.
Alexandra M. Miller, MD Dr. Miller has nothing to disclose.
Nara Michaelson, MD The institution of Dr. Michaelson has received research support from Biogen. The institution of Dr. Michaelson has received research support from the National Multiple Sclerosis Society (NMSS).
David French Mr. French has nothing to disclose.
Gero Lindenblatt, MD Mr. Lindenblatt has nothing to disclose.
Spencer Churchill McFarlane, MD, JD Dr. McFarlane has nothing to disclose.
Jorge Maurino Jorge Maurino has received personal compensation for serving as an employee of Roche Pharma Spain, Medical Department.
Brian Steingo, MD Dr. Steingo has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biogen, EMD Serono, Bristol Myers, Sanofi, Janssen. Dr. Steingo has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biogen, EMD Serono, Bristol Myers, Sanofi, Janssen. The institution of Dr. Steingo has received research support from Infinity Clinical Research.
Sami L. Khella, MD, FAAN Dr. Khella has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Ionis. Dr. Khella has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Ionis. Dr. Khella has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Pfizer. Dr. Khella has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alnylam. Dr. Khella has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Eidos.
Anastasia Vishnevetsky, MD The institution of Dr. Vishnevetsky has received research support from National MS Society. The institution of Dr. Vishnevetsky has received research support from NIH (NeuroNext).
Kerstin Hellwig Kerstin Hellwig has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Teva . Kerstin Hellwig has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen . Kerstin Hellwig has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis . Kerstin Hellwig has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche . Kerstin Hellwig has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck . Kerstin Hellwig has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genzyme . Kerstin Hellwig has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bayer . Kerstin Hellwig has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BMS. Kerstin Hellwig has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen . Kerstin Hellwig has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for INC research . Kerstin Hellwig has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis . Kerstin Hellwig has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche . Kerstin Hellwig has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Merck . Kerstin Hellwig has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen . Kerstin Hellwig has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Bayer . The institution of Kerstin Hellwig has received research support from Roche . The institution of Kerstin Hellwig has received research support from Merck . The institution of Kerstin Hellwig has received research support from Biogen. The institution of Kerstin Hellwig has received research support from Genzyme . The institution of Kerstin Hellwig has received research support from Novartis . The institution of Kerstin Hellwig has received research support from TEVA.
Markus Kowarik Markus Kowarik has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck, Roche, Celgene, Sanofi-Genzyme, Novartis and Biogen. The institution of Markus Kowarik has received research support from Merck. The institution of Markus Kowarik has received research support from Sanofi Genzyme.
Sweatha Reddy, Other Mrs. Reddy has received personal compensation for serving as an employee of FTDDR.
Mark Buchfuhrer No disclosure on file
Stephen Bevan Shrewsbury, MD Dr. Shrewsbury has received personal compensation for serving as an employee of Impel NeuroPharma. Dr. Shrewsbury has received stock or an ownership interest from Impel NeuroPharma.
Maria Elisa Samaniego, MD Dr. Samaniego has nothing to disclose.
John W. Rose, MD, FAAN The institution of Dr. Rose has received research support from National Multiple Sclerosis Society. The institution of Dr. Rose has received research support from Guthy Jackson Charitable Foundation. The institution of Dr. Rose has received research support from NIH . The institution of Dr. Rose has received research support from VA. The institution of Dr. Rose has received research support from Biogen. The institution of Dr. Rose has received research support from Friends of MS. Dr. Rose has received intellectual property interests from a discovery or technology relating to health care.
Awab Kamal Mamoud Elnaeem, MD Dr. Kamal Mamoud Elnaeem has nothing to disclose.
Robin Striar, Other Ms. Striar has nothing to disclose.
Cinzia Valeria Russo Cinzia Valeria Russo has nothing to disclose.
Edward Yang, MD,PhD The institution of Dr. Yang has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Syngeos.
Brian LaBarre Mr. LaBarre has nothing to disclose.
Denise Hsu, MD,PhD Dr. Hsu has received personal compensation for serving as an employee of Henry M. Jackson Foundation for the Advancement of Military Medicine. The institution of Dr. Hsu has received research support from US Military HIV Research Program.
Javier *Use 290687 Sotoca, MD Mr. Sotoca has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bayer. Mr. Sotoca has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Mr. Sotoca has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Mr. Sotoca has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Mr. Sotoca has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Mr. Sotoca has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen.
Jessica McDermott, MD Dr. McDermott has nothing to disclose.
Christopher Paul Kellner, MD Christopher Kellner has nothing to disclose.
Ralitza H. Gavrilova, MD Dr. Gavrilova has nothing to disclose.
Mohammad Alkhoujah, MD Dr. Alkhoujah has nothing to disclose.
Amira Salim Miss Salim has nothing to disclose.
Leorah Aude Emmanuelle Freeman, MD, PhD Dr. Freeman has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis. Dr. Freeman has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Hoffman La-Roche. Dr. Freeman has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Bristol Myers Squibb. Dr. Freeman has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech, Inc. Dr. Freeman has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for EMD Serono. Dr. Freeman has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Horizon. Dr. Freeman has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Freeman has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Sanofi-Genzyme. Dr. Freeman has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Texas Neurological Society. Dr. Freeman has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for WebMD. Dr. Freeman has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for MSAA. The institution of Dr. Freeman has received research support from Genentech. The institution of Dr. Freeman has received research support from NIH/NINDS. The institution of Dr. Freeman has received research support from NIH/NINDS. The institution of Dr. Freeman has received research support from PCORI. The institution of Dr. Freeman has received research support from EMD Serono. Dr. Freeman has received personal compensation in the range of $500-$4,999 for serving as a Participant in educational interview with Multiple Sclerosis Association of America.
Zuha Majid Miss Majid has nothing to disclose.
Giovanna Pellecchia, PhD Dr. Pellecchia has nothing to disclose.
Ritesh Thapa, MD Dr. Thapa has stock in Alibaba Group Holding Limited,Exro Technologies Inc, Drone Delivery Canada Corp, Vanguard S&P 500 ETF, Nokia Corp.
Muriel Stoppe Muriel Stoppe has nothing to disclose.
Chi-Ying (Roy) Lin, MD, FAAN Dr. Lin has a non-compensated relationship as a Secretary with Broadway for Ataxia Foundation (a 501 (c) (3) non-profit organization) that is relevant to AAN interests or activities.
John William Lindsey, MD Dr. Lindsey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech. Dr. Lindsey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Banner Life Sciences. Dr. Lindsey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for TG Therapeutics. Dr. Lindsey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Mapi. Dr. Lindsey has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Teva. The institution of Dr. Lindsey has received research support from Genentech.
Aziz I. Shaibani, MD, FAAN Dr. Shaibani has nothing to disclose.
Justin Abbatemarco, MD Dr. Abbatemarco has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for EMD Serono. Dr. Abbatemarco has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Horizon. Dr. Abbatemarco has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech . Dr. Abbatemarco has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TG Therapeutics, Inc.. The institution of Dr. Abbatemarco has received research support from Horizon.
Elizabeth M. Berry-Kravis, MD, PhD The institution of Dr. Berry-Kravis has received research support from NIH. The institution of Dr. Berry-Kravis has received research support from Ionis. The institution of Dr. Berry-Kravis has received research support from Zynerba. The institution of Dr. Berry-Kravis has received research support from Roche. The institution of Dr. Berry-Kravis has received research support from CDC. The institution of Dr. Berry-Kravis has received research support from FRAXA Research Foundation. The institution of Dr. Berry-Kravis has received research support from GeneTx. The institution of Dr. Berry-Kravis has received research support from Angelman Syndrome Foundation. The institution of Dr. Berry-Kravis has received research support from Acadia. The institution of Dr. Berry-Kravis has received research support from Ultragenyx. The institution of Dr. Berry-Kravis has received research support from Anavex. The institution of Dr. Berry-Kravis has received research support from Rett Syndrome Research Trust. The institution of Dr. Berry-Kravis has received research support from Ultragenyx. The institution of Dr. Berry-Kravis has received research support from Mallinckrodt. The institution of Dr. Berry-Kravis has received research support from Together Strong Foundation. The institution of Dr. Berry-Kravis has received research support from Orphazyme. The institution of Dr. Berry-Kravis has received research support from Taysha. The institution of Dr. Berry-Kravis has received research support from Erydel. The institution of Dr. Berry-Kravis has received research support from Tetra. The institution of Dr. Berry-Kravis has received research support from Neuren. The institution of Dr. Berry-Kravis has received research support from FRAXA Research Foundation.
Mailam Eltity Dr. Eltity has nothing to disclose.
Julette F. Batara, MD Dr. Batara has nothing to disclose.
Kholoud Yaser Altarazi, MD Dr. Altarazi has nothing to disclose.
Hend Al Hodaif, MBBS Dr. Al Hodaif has nothing to disclose.
Maharshi Pandya Mr. Pandya has nothing to disclose.
Ralf Linker Dr. Linker has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Linker has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Springer. The institution of Dr. Linker has received research support from Novartis. The institution of Dr. Linker has received research support from Biogen.
Di Di An, PhD Ms. Di An has nothing to disclose.
Jason H. Margolesky, MD Dr. Margolesky has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion . The institution of Dr. Margolesky has received research support from NeuroNext.
Allison P. Navis, MD The institution of Dr. Navis has received research support from NIH Loan Repayment Program.
Chetan Chandrakant Vekhande, MD, MBBS Dr. VEKHANDE has nothing to disclose.
Samiksha Srivastava, MD Dr. Srivastava has nothing to disclose.
Emily S. Riser, MD Dr. Riser has nothing to disclose.
Kanika Sharma Ms. Sharma has nothing to disclose.
Richard B. Lipton, MD, FAAN Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Allergan/Abbvie. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Amgen. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biohaven. Dr. Lipton has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Eli Lilly. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Lundbeck. Dr. Lipton has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for GlaxoSmithKline. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Teva. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Vedanta. Dr. Lipton has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Grifols. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Pfizer. Dr. Lipton has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Axon. Dr. Lipton has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Satsuma. Dr. Lipton has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech. Dr. Lipton has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cool Tech. Dr. Lipton has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BDSI. Dr. Lipton has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Linpharma. Dr. Lipton has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Allergan/Abbvie. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biohaven. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Eli Lilly. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lundbeck. Dr. Lipton has stock in Biohaven. Dr. Lipton has stock in Manistee. Dr. Lipton has stock in Axon. Dr. Lipton has stock in CoolTech. The institution of Dr. Lipton has received research support from Teva. The institution of Dr. Lipton has received research support from Amgen. The institution of Dr. Lipton has received research support from Allergan/Abbvie. The institution of Dr. Lipton has received research support from Gammacore. The institution of Dr. Lipton has received research support from Axsome. The institution of Dr. Lipton has received research support from Charleston Labs. The institution of Dr. Lipton has received research support from Eli Lilly. The institution of Dr. Lipton has received research support from Satsuma. The institution of Dr. Lipton has received research support from NIH . The institution of Dr. Lipton has received research support from Veterans Administration. Dr. Lipton has received publishing royalties from a publication relating to health care.
Xin Ying Lee, Other Ms. Lee has received personal compensation for serving as an employee of Lundbeck A/S.
Ron Cohen, MD Dr. Cohen has received personal compensation for serving as an employee of Acorda Therapeutics. Dr. Cohen has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for VBL Therapeutics. Dr. Cohen has stock in Acorda Therapeutics.
Tanis J. Ferman Ms. Ferman has nothing to disclose.
Jeffrey B. English, MD Dr. English has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for biogen idec. Dr. English has received personal compensation in the range of $500-$4,999 for serving as a Consultant for bristol myer squibb. Dr. English has received personal compensation in the range of $500-$4,999 for serving as a Consultant for genentech. Dr. English has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for sanofi genzyme. Dr. English has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for biogen idec. Dr. English has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for genzyme. Dr. English has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for genentech. Dr. English has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for bristol myer squibb. Dr. English has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for TG Therpeutics. Dr. English has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for EMD Serono. Dr. English has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for swift currie. Dr. English has received intellectual property interests from a discovery or technology relating to health care.
Carlo S. Tornatore, MD Dr. Tornatore has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Serono. Dr. Tornatore has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi. Dr. Tornatore has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. Dr. Tornatore has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Biogen.
Makbule Senel Makbule Senel has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion, Bayer, Biogen, Merck, Roche, and Sanofi Genzyme.
Ashley Robertson Ashley Robertson has received personal compensation for serving as an employee of Hesperos, Inc.. Ashley Robertson has stock in Hesperos, Inc..
Melissa Armstrong, MD, MSc, FAAN The institution of Dr. Armstrong has received research support from National Institute of Aging. The institution of Dr. Armstrong has received research support from Florida Department of Health. The institution of Dr. Armstrong has received research support from Lewy Body Dementia Association. Dr. Armstrong has received research support from Parkinson Foundation. Dr. Armstrong has received personal compensation in the range of $5,000-$9,999 for serving as a DSMB member with Alzheimer's Clinical Trials Consortium. Dr. Armstrong has received personal compensation in the range of $5,000-$9,999 for serving as a DSMB member with Alzheimer's Disease Cooperative Study. Dr. Armstrong has a non-compensated relationship as a Member, Scientific Advisory Council with Lewy Body Dementia Association that is relevant to AAN interests or activities.
Jeremy Moeller, MD, FAAN Dr. Moeller has received publishing royalties from a publication relating to health care.
Larry Charleston, IV, MD, MSc, FAHS Dr. Charleston has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Allergan/AbbVie. Dr. Charleston has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biohaven Biopharmaceuticals. Dr. Charleston has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Teva Pharmaceuticals. Dr. Charleston has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amneal Pharmaceuticals. Dr. Charleston has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Satsuma Pharmaceuticals. Dr. Charleston has received personal compensation in the range of $500-$4,999 for serving as a Consultant for LinPharma. Dr. Charleston has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Haleon. Dr. Charleston has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Pfizer. Dr. Charleston has a non-compensated relationship as a Associate Editor with Headache Journal: The Journal of Head and Face Pain that is relevant to AAN interests or activities. Dr. Charleston has a non-compensated relationship as a Board Member at Large with Alliance for Headache Disorders Advocacy that is relevant to AAN interests or activities. Dr. Charleston has a non-compensated relationship as a Board Member with Clinical Neurological Society of America that is relevant to AAN interests or activities.
Mark Mintz, MD, FAAN The institution of Dr. Mintz has received research support from Curemark. The institution of Dr. Mintz has received research support from Otsuka.
Brian G. Weinshenker, MD, FAAN Dr. Weinshenker has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Mitsubishi Tanabe. Dr. Weinshenker has received personal compensation in the range of $500-$4,999 for serving as a Consultant for CANbridge Pharmaceuticals. Dr. Weinshenker has received personal compensation in the range of $0-$499 for serving as a Consultant for CALIBR. Dr. Weinshenker has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Horizon. Dr. Weinshenker has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Weinshenker has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Viela Bio. Dr. Weinshenker has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche Group (Chugai, Genentech, Roche). Dr. Weinshenker has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB Pharmaceuticals. The institution of Dr. Weinshenker has received research support from Guthy Jackson Charitable Foundation. Dr. Weinshenker has received intellectual property interests from a discovery or technology relating to health care. Dr. Weinshenker has received personal compensation in the range of $5,000-$9,999 for serving as a speaker at internal meeting and symposium with Horizon.
Enrique Gomez Figueroa, MD, MSc Dr. Gomez Figueroa has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen Mexico. Dr. Gomez Figueroa has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Astra Zeneca Mexico. Dr. Gomez Figueroa has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Johnson & Johnson LATAM.
Danny Bega, MD Dr. Bega has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Teva Pharmaceuticals. Dr. Bega has received personal compensation in the range of $500-$4,999 for serving as a Consultant for GE Healthcare. Dr. Bega has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Acadia Pharmaceuticals. Dr. Bega has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion Pharmaceuticals. Dr. Bega has received personal compensation in the range of $500-$4,999 for serving as a Consultant for WebMD. Dr. Bega has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Teva Pharmaceuticals. Dr. Bega has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Acorda Therapeutics. Dr. Bega has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Neurocrine Biosciences. Dr. Bega has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Kyowa Kirin. Dr. Bega has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Supernus Pharmaceuticals. Dr. Bega has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Abbvie. Dr. Bega has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sunovion. Dr. Bega has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for ACTN / ANA. The institution of Dr. Bega has received research support from Huntington Disease Society of America. The institution of Dr. Bega has received research support from Parkinson Foundation.
Connor David Welsh, DO Dr. Welsh has nothing to disclose.
Yan Li, PhD Dr. Li has received personal compensation for serving as an employee of Apellis Pharmaceuticals, Inc.
Genise Ane Tremain, RN Ms. Tremain has nothing to disclose.
Christopher J. Fitzpatrick, PhD Dr. Fitzpatrick has received personal compensation for serving as an employee of Impel Pharmaceuticals.
Omar Choudri No disclosure on file
Jeremiah Aakre Jeremiah Aakre has nothing to disclose.
Laura Borrega Canelo, Sr., MD Dr. Borrega Canelo has nothing to disclose.
Nancy M. Nealon, MD Dr. Nealon has nothing to disclose.
Merry Chen, MD Dr. Chen has nothing to disclose.
Susanna O'Kula, MD Dr. O'Kula has nothing to disclose.
Moises Garces Redondo, MD Mr. Garces Redondo has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen. Mr. Garces Redondo has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sanofi. Mr. Garces Redondo has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Almirall. Mr. Garces Redondo has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Novartis.
Scott Husak Scott Husak has nothing to disclose.
Kathryn Wyman-Chick, Psyd Dr. Wyman-Chick has received research support from NIH/NIA.
Mikael Guzman Karlsson, MD, PhD An immediate family member of Dr. Guzman Karlsson has received personal compensation for serving as an employee of Ventyx Biosciences, Inc..
Klemens Angstwurm, MD Dr. Angstwurm has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Angstwurm has received personal compensation in the range of $500-$4,999 for serving as a Consultant for TEVA.
Evanthia Bernitsas, MD, FAAN Dr. Bernitsas has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Janssen@Janssen. Dr. Bernitsas has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Biogen. The institution of Dr. Bernitsas has received research support from Roche/Genentech.
Shitiz K. Sriwastava, MBBS Dr. Sriwastava has nothing to disclose.
Sarah Kristine Skinner, PhD Dr. Skinner has received personal compensation for serving as an employee of Hesperos Inc.
Paola Valsasina Paola Valsasina has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for ACCMED.
Sandeep Bhatt Sandeep Bhatt has nothing to disclose.
Zainab Mehdi Miss Mehdi has nothing to disclose.
Naotake Yanagisawa, PhD Mr. Yanagisawa has nothing to disclose.
Cristina Jageka, MD Miss Jageka has nothing to disclose.
Elizabeth Monohan, MD Dr. Monohan has nothing to disclose.
Ofer Sadan Ofer Sadan has received intellectual property interests from a discovery or technology relating to health care.
Jamie Walker, MD,PhD Dr. Walker has nothing to disclose.
Ron Josef Danziger, MD Dr. Danziger has nothing to disclose.
Jenny Meyer, MD The institution of Dr. Meyer has received research support from Grifols. The institution of Dr. Meyer has received research support from Medicinova.
Michael Smith No disclosure on file
Gabriel Pardo, MD, FAAN Dr. Pardo has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Roche Genentech. Dr. Pardo has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi Genzyme. Dr. Pardo has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for EMD Serono. Dr. Pardo has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis. Dr. Pardo has received personal compensation in the range of $500-$4,999 for serving as a Consultant for TG Therapeutics. Dr. Pardo has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Horizon. Dr. Pardo has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen. Dr. Pardo has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Bristol Myers Squibb. Dr. Pardo has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for EMD Serono. Dr. Pardo has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Dr. Pardo has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Roche Genentech. Dr. Pardo has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Janssen. Dr. Pardo has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Sanofi Genzyme. Dr. Pardo has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for TG Therapeutics. Dr. Pardo has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Horizon Therapeutics. Dr. Pardo has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alexion Pharmaceuticals.
Archana Anil Patel, MD Dr. Patel has received research support from NIH/NINDS.
Steven Kymes Steven Kymes has received personal compensation for serving as an employee of Lundbeck. Steven Kymes has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for American Journal of Ophthalmology. Steven Kymes has received research support from Emmes Corporation.
Fernando J. Caceres, MD No disclosure on file
Erik Uhlmann, MD Dr. Uhlmann has nothing to disclose.
Corinna Trebst No disclosure on file
M. Mateo Paz Soldan, MD, PhD Dr. Paz Soldan has received personal compensation in the range of $500-$4,999 for serving as a Consultant for TG Therapeutics. The institution of Dr. Paz Soldan has received research support from National Institutes of Health. The institution of Dr. Paz Soldan has received research support from National Multiple Sclerosis Society. The institution of Dr. Paz Soldan has received research support from Western Institute for Biomedical Research. The institution of Dr. Paz Soldan has received research support from Biogen. The institution of Dr. Paz Soldan has received research support from Novartis. The institution of Dr. Paz Soldan has received research support from Clene Nanomedicine.
Lisa Ferayorni, MD Dr. Ferayorni has nothing to disclose.
Erin M. Dunbar, MD Dr. Dunbar has nothing to disclose.
Habib Georges Moutran Barroso, MD Dr. Moutran Barroso has nothing to disclose.
Brook Centofanti, DO Dr. Centofanti has nothing to disclose.
Ninad Desai, MBBS Dr. Desai has nothing to disclose.
Sama Noroozi Gilandehi, MD Dr. Noroozi Gilandehi has nothing to disclose.
Khaled Al Robaidi, MD Dr. Al Robaidi has nothing to disclose.
Sydney Carter Ms. Carter has nothing to disclose.
Tigwa Davis, PhD Dr. Davis has received personal compensation for serving as an employee of Health Analytics,LLC. The institution of Dr. Davis has received research support from Acadia Pharmaceuticals .
Robert Vann, PhD Dr. Vann has received personal compensation for serving as an employee of Impel Neuropharma. Dr. Vann has received personal compensation for serving as an employee of Biogen.
Sutapa Ray, PhD Dr. Ray has received personal compensation for serving as an employee of Impel Pharmaceuticals. Dr. Ray has stock in Impel Pharmaceuticals.
James Walker Wiggins, MD, PhD Dr. Wiggins has nothing to disclose.
Douglas Aaron Wells, Jr., MD Dr. Wells has nothing to disclose.
Siya Sawan, Other Ms. Sawan has nothing to disclose.
Christian Schinke No disclosure on file
Stephanie Jarvis Stephanie Jarvis has nothing to disclose.
Tracy Tholanikunnel, MD Dr. Tholanikunnel has nothing to disclose.
Volkan Mert Abayli, Jr. Mr. ABAYLI has nothing to disclose.
Daniel Serrano, PhD The institution of Dr. Serrano has received research support from NIH/FDA.
Amir Dori, MD, PhD Dr. Dori has received personal compensation in the range of $500-$4,999 for serving as a Consultant for TEVA. Dr. Dori has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Takeda . Dr. Dori has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi. Dr. Dori has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Medison Pharma. Dr. Dori has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Medison Pharma. The institution of Dr. Dori has received research support from Biogen. The institution of Dr. Dori has received research support from Pfizer. The institution of Dr. Dori has received research support from Alnylam therapeutics. Dr. Dori has received intellectual property interests from a discovery or technology relating to health care.
Aldana Marinangeli Aldana Marinangeli has nothing to disclose.
Ana María Alonso Torres, MD Dr. Alonso Torres has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Janssen. Dr. Alonso Torres has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Alonso Torres has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis.
Romain Marignier, MD, PhD Dr. Marignier has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB. Dr. Marignier has received personal compensation in the range of $0-$499 for serving as a Consultant for ALEXION. Dr. Marignier has received personal compensation in the range of $500-$4,999 for serving as a Consultant for ROCHE. Dr. Marignier has received personal compensation in the range of $500-$4,999 for serving as a Consultant for HORIZON THERAPEUTICS. Dr. Marignier has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for ROCHE.
Craig D. Blackstone, MD, PhD Dr. Blackstone has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Guidepoint. Dr. Blackstone has received personal compensation in the range of $500-$4,999 for serving as a Consultant for FIrstThought. Dr. Blackstone has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Asha Therapeutics. Dr. Blackstone has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Ficksman & Conley, LLP.
Hesham Ahmed Abboud, MD Dr. Abboud has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. The institution of Dr. Abboud has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Genentech . Dr. Abboud has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. Dr. Abboud has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Horizon. Dr. Abboud has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BMS. Dr. Abboud has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alpine Pharma. Dr. Abboud has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Abboud has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Abboud has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Horizon. Dr. Abboud has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Cycle Pharma. Dr. Abboud has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Axonics. Dr. Abboud has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Biogen. Dr. Abboud has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Genentech. Dr. Abboud has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for BMS. Dr. Abboud has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alexion . Dr. Abboud has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Horizon. The institution of Dr. Abboud has received research support from Genentech . The institution of Dr. Abboud has received research support from Novartis. The institution of Dr. Abboud has received research support from BMS. The institution of Dr. Abboud has received research support from Sanofi-Genzyme. The institution of Dr. Abboud has received research support from The Guthy-Jackson Charitable Foundation. Dr. Abboud has received publishing royalties from a publication relating to health care.
Francesco Sacca, MD Dr. Sacca has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Alexion. Dr. Sacca has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Argenx. Dr. Sacca has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Lexeo. Dr. Sacca has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. Dr. Sacca has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genpharm. Dr. Sacca has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Sacca has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Medpharma. Dr. Sacca has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Madison Pharma. Dr. Sacca has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Zai Lab. Dr. Sacca has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Dianthus. Dr. Sacca has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Reata. Dr. Sacca has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sandoz. The institution of Dr. Sacca has received research support from AIFA. The institution of Dr. Sacca has received research support from FARA.
Uwe Zettl Uwe Zettl has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Merck Serono. Uwe Zettl has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alexion . Uwe Zettl has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Bayer. Uwe Zettl has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. Uwe Zettl has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Teva. The institution of Uwe Zettl has received research support from BMBF(Government).
Clifford A. Reed, MD No disclosure on file
Somchai Sriplienchan, MD Dr. Sriplienchan has nothing to disclose.
Jaroslaw Dulski Dr. Dulski has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for VM Media Ltd.. Dr. Dulski has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Radoslaw Lipinski 90 Consulting. Dr. Dulski has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Ipsen. Dr. Dulski has received research support from Polish Neurological Society. Dr. Dulski has received research support from Polish National Agency for Academic Exchange.
Torsten Kraya, MD Dr. Kraya has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TEVA, Novartis, Lilly. Dr. Kraya has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for TEVA, Novartis, Lilly, Hormosan, Abbvie.
Vincenzo Brescia Morra, MD Dr. Brescia Morra has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Brescia Morra has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for NOVARTIS. Dr. Brescia Morra has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for BIOGEN. Dr. Brescia Morra has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for ROCHE. Dr. Brescia Morra has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TEVA. Dr. Brescia Morra has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for ALMIRALL. Dr. Brescia Morra has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for MERK. Dr. Brescia Morra has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for MERK. The institution of Dr. Brescia Morra has received research support from FISM. Dr. Brescia Morra has a non-compensated relationship as a PI with FISM that is relevant to AAN interests or activities.
Ho Jin Kim, MD Dr. Kim has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Aprilbio, HanAll BioPharma, Viela Bio. Dr. Kim has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alexion, Biogen, Celltrion, Eisai, Merck Serono, Novartis, Sanofi Genzyme, Teva-Handok. Dr. Kim has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Multiple Sclerosis Journal, Journal of Clinical Neurology.
Jan Wllem Willem Gorter, MD,PhD Dr. Gorter has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Wiley. Dr. Gorter has received research support from McMaster University.
Obada Ahmad Al Jayyousi, MD Dr. Al Jayyousi has nothing to disclose.
Shuodan Zhang, MD Dr. Zhang has nothing to disclose.
Omar *use 393242 Hamdan Mr. Hamdan has nothing to disclose.
Adam L. Boxer, MD, PhD An immediate family member of Dr. Boxer has received personal compensation for serving as an employee of Kaiser Permanente. Dr. Boxer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ono. Dr. Boxer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Third Rock. Dr. Boxer has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Transposon. Dr. Boxer has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Roche. Dr. Boxer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Oligomerix. Dr. Boxer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for GSK. Dr. Boxer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Humana. Dr. Boxer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Wave. Dr. Boxer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Boehringer Ingelheim. Dr. Boxer has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Oscotec. Dr. Boxer has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Arvinas. Dr. Boxer has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Arkuda. Dr. Boxer has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AZTherapeutics. Dr. Boxer has stock in Alector. Dr. Boxer has stock in Arkuda. Dr. Boxer has stock in Arvinas. An immediate family member of Dr. Boxer has stock in AZtherapies. Dr. Boxer has stock in TrueBinding. The institution of Dr. Boxer has received research support from Biogen. The institution of Dr. Boxer has received research support from Eisai. The institution of Dr. Boxer has received research support from Regeneron. The institution of Dr. Boxer has received research support from NIH. The institution of Dr. Boxer has received research support from Bluefield Project. Dr. Boxer has received research support from Rainwater Charitable Foundation. The institution of Dr. Boxer has received research support from Association for Frontotemporal Degeneration.
Dipali P. Nemade, MD Dr. Nemade has nothing to disclose.
Esther H. Nie, PhD An immediate family member of Dr. Nie has received personal compensation for serving as an employee of Collective Acumen . Dr. Nie has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Medidata, Acorn AI.
Brigitte Wildemann, MD Dr. Wildemann has nothing to disclose.
Aimen Nadeem Miss Nadeem has nothing to disclose.
Dhanalakshmi Angappan, MD Dr. Angappan has nothing to disclose.
Jo Wilmshurst, MD,MBBS Prof. Wilmshurst has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for SANOFI. Prof. Wilmshurst has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Wiley.
Divya Asher Divya Asher has received personal compensation for serving as an employee of Lundbeck. Divya Asher has received personal compensation for serving as an employee of AbbVie.
James F. Sumowski Mr. Sumowski has nothing to disclose.
Li Zhigang Li Zhigang has nothing to disclose.
Jason Sciarretta, MD Dr. Sciarretta has nothing to disclose.
Animesh Das, MD Dr. Das has nothing to disclose.
Emily Kim Ms. Kim has received personal compensation for serving as an employee of IQVIA.
Behnam Sabayan, MD, PhD, MSPH Dr. Sabayan has nothing to disclose.
Darcy L. Fehlings The institution of Darcy L. Fehlings has received research support from Ontario Brain Institute. The institution of Darcy L. Fehlings has received research support from Kids Brain Health Network. The institution of Darcy L. Fehlings has received research support from CHILD BRIGHT. Darcy L. Fehlings has received personal compensation in the range of $500-$4,999 for serving as a Member of the Selection Committee for the Elsass Foundation CP Research Prize with Elsass Foundation .
Jairo Alejandro Gaitan Alfonso, MD Dr. Gaitan Alfonso has nothing to disclose.
Eric D. Marsh, MD, PhD Dr. Marsh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Acadia Pharmacuticals. Dr. Marsh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Stoke Therapeutics. Dr. Marsh has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Acadia Pharmaceuticals. The institution of Dr. Marsh has received research support from NIH. The institution of Dr. Marsh has received research support from Rett Syndrome Research Trust. The institution of Dr. Marsh has received research support from International Rett Syndrome Foundation. The institution of Dr. Marsh has received research support from Eagles Autism Challenge. The institution of Dr. Marsh has received research support from LouLou Foundation. The institution of Dr. Marsh has received research support from International CDKL5 Resarch Foundation. The institution of Dr. Marsh has received research support from Acadia Pharmaceuticals. The institution of Dr. Marsh has received research support from Marinus. The institution of Dr. Marsh has received research support from Stoke Therapeutics. The institution of Dr. Marsh has received research support from Takeda Pharmaceuticals. Dr. Marsh has received personal compensation in the range of $500-$4,999 for serving as a Grant Review with NIH. Dr. Marsh has received personal compensation in the range of $5,000-$9,999 for serving as a Expert Witness with Department of Human Services. Dr. Marsh has received personal compensation in the range of $500-$4,999 for serving as a Speaker with Medscape.
Sarika Peters, PhD Dr. Peters has nothing to disclose.
Trieste Francis Miss Francis has nothing to disclose.
Tomoyasu Bunai, MD,PhD Dr. Bunai has nothing to disclose.
Adrian Kielhorn Adrian Kielhorn has received personal compensation for serving as an employee of Alexion. Adrian Kielhorn has stock in Alexion.
Rohan Arora, MD The institution of Dr. Arora has received research support from Bayer.
Grace Tworek, Other Dr. Tworek has nothing to disclose.
Brian Drachman Brian Drachman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alnylam. Brian Drachman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Akcea.
Kathryn Bowdoin Lalor, MD Dr. Lalor has nothing to disclose.
Andrea Formella, PharmD, BCPP Dr. Formella has received personal compensation for serving as an employee of Adamas Pharmaceuticals, Inc. Dr. Formella has received personal compensation for serving as an employee of Supernus Pharmaceuticals, Inc. Dr. Formella has stock in Adamas Pharmaceuticals. Dr. Formella has stock in Supernus Pharmaceuticals, Inc..
Patrick Steven Brennan Mr. Brennan has stock in Immuneering Corp.
Jan-Mendelt Tillema, MD Dr. Tillema has nothing to disclose.
Antonio Carotenuto Mr. Carotenuto has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Merk, Novartis, Roche and Almirall. The institution of Mr. Carotenuto has received research support from ALMIRALL. The institution of Mr. Carotenuto has received research support from Carotenuto Antonio.
Muneeb Niazi, DO Dr. Niazi has nothing to disclose.
Dmitry Khaitov, MD Dr. Khaitov has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Biogen.
Yang Mao-Draayer, MD Dr. Mao-Draayer has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biogen Idec. Dr. Mao-Draayer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for EMD Serono. Dr. Mao-Draayer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genzyme-Sanofi. Dr. Mao-Draayer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech. Dr. Mao-Draayer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen . Dr. Mao-Draayer has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Horizone . Dr. Mao-Draayer has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genzyme-Sanofi. Dr. Mao-Draayer has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Mao-Draayer has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Horizone. Dr. Mao-Draayer has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Biogen Idec. Dr. Mao-Draayer has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Janssen. The institution of Dr. Mao-Draayer has received research support from NIH . The institution of Dr. Mao-Draayer has received research support from Genzyme-Sanofi. The institution of Dr. Mao-Draayer has received research support from Novartis. The institution of Dr. Mao-Draayer has received research support from Genentech.
James E. Galvin, MD, MPH No disclosure on file
Camilla Cividini, MSc Ms. Cividini has nothing to disclose.
Huimahn Alex Choi, MD The institution of Dr. Choi has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Acasti Pharma.
Samira Apostolos-Pereira Samira Apostolos-Pereira has nothing to disclose.
Abhijit Rao Mr. Rao has nothing to disclose.
Yu-Ting Chen, MD Dr. Chen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alnylam.
Anagha Srikanth, Other Miss Srikanth has nothing to disclose.
Jorge Torres Ortiz Jorge Torres Ortiz has nothing to disclose.
Purva Parab, PhD Dr. Parab has received personal compensation for serving as an employee of Health Analytics, LLC.. The institution of Dr. Parab has received research support from Acadia.
Alexander Emmer, MD Dr. Emmer has nothing to disclose.
Vyanka Redenbaugh, MB BCh BAO Dr. Redenbaugh has nothing to disclose.
Jennifer L. Howe, Other Ms. Howe has nothing to disclose.
Aminu Aliyar Ms. Aliyar has nothing to disclose.
Joseph A. Diamond, MD An immediate family member of Dr. Diamond has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Consultant360. An immediate family member of Dr. Diamond has received publishing royalties from a publication relating to health care.
Thiago Duque Pinheiro, MD Dr. Pinheiro has nothing to disclose.
Jeremy Syrjanen Jeremy Syrjanen has nothing to disclose.
Seema Soni-Brahmbhatt Seema Soni-Brahmbhatt has nothing to disclose.
Jennie W. Mah, RN Mrs. Mah has nothing to disclose.
Angad Chhabra Mr. Chhabra has nothing to disclose.
Julio Dotor Garcia-Soto JULIO DOTOR GARCÍA-SOTO has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck . JULIO DOTOR GARCÍA-SOTO has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Merck, Biogen, Sanofi-Genzyme, Almirall, Teva, UCB, Novartis.
Nitai Das Mukhopadhyay, PhD Dr. Mukhopadhyay has stock in Microsoft, Apple, Amazon, Disney. The institution of Dr. Mukhopadhyay has received research support from NIH.
Neil Saini Mr. Saini has nothing to disclose.
Tarannum Behlim, MD,Other Dr. Behlim has nothing to disclose.
Jeffrey E. Dunn, MD, FAAN Dr. Dunn has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. Dr. Dunn has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen. Dr. Dunn has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BMS. Dr. Dunn has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genzyme. The institution of Dr. Dunn has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Progentec Diagnostics.
Sabrina Aimola, Other Ms. Aimola has nothing to disclose.
Henry L. Paulson, MD, PhD, FAAN Dr. Paulson has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Exicure. The institution of Dr. Paulson has received research support from National Institutes of Health. Dr. Paulson has a non-compensated relationship as a Member, Nominating committee with American Neurological Association that is relevant to AAN interests or activities.
Orrin Devinsky, MD, FAAN Dr. Devinsky has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eisai. Dr. Devinsky has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for California Cannabis Enterprises. Dr. Devinsky has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Engage. Dr. Devinsky has received personal compensation in the range of $50,000-$99,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Privateer Holdings. Dr. Devinsky has received personal compensation in the range of $1,000,000+ for serving on a Scientific Advisory or Data Safety Monitoring board for Receptor Holdings. Dr. Devinsky has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Rettco. Dr. Devinsky has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Silver Spike. Dr. Devinsky has received personal compensation in the range of $100,000-$499,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Tevard. Dr. Devinsky has received personal compensation in the range of $1,000,000+ for serving on a Scientific Advisory or Data Safety Monitoring board for Tilray. Dr. Devinsky has received personal compensation in the range of $100,000-$499,999 for serving as an officer or member of the Board of Directors for Engage. Dr. Devinsky has received personal compensation in the range of $50,000-$99,999 for serving as an officer or member of the Board of Directors for Tevard Biosciences. Dr. Devinsky has received stock or an ownership interest from Engage. Dr. Devinsky has received stock or an ownership interest from Empatica. Dr. Devinsky has received stock or an ownership interest from California Cannabis Enterprises. Dr. Devinsky has received stock or an ownership interest from Empatica. Dr. Devinsky has received stock or an ownership interest from Silver Spike. Dr. Devinsky has received stock or an ownership interest from Docklight Brands. Dr. Devinsky has received stock or an ownership interest from Egg Rock/Papa Barkley. Dr. Devinsky has received stock or an ownership interest from Leafly. Dr. Devinsky has received stock or an ownership interest from Left Coast Ventures. Dr. Devinsky has received stock or an ownership interest from Privateer Holdings. Dr. Devinsky has received stock or an ownership interest from Receptor Holdings. Dr. Devinsky has received stock or an ownership interest from Qstate. The institution of Dr. Devinsky has received research support from GW Pharma. The institution of Dr. Devinsky has received research support from Zogenix. The institution of Dr. Devinsky has received research support from PTC Pharma. The institution of Dr. Devinsky has received research support from NIH. The institution of Dr. Devinsky has received research support from DOD. The institution of Dr. Devinsky has received research support from NIH. The institution of Dr. Devinsky has received research support from Epilepsy Foundation. The institution of Dr. Devinsky has received research support from NIH. The institution of Dr. Devinsky has received research support from NIH. The institution of Dr. Devinsky has received research support from NSF. Dr. Devinsky has received intellectual property interests from a discovery or technology relating to health care. Dr. Devinsky has received intellectual property interests from a discovery or technology relating to health care. Dr. Devinsky has received publishing royalties from a publication relating to health care.
Gabriela Romanow, Other Ms. Romanow has received research support from Freeman Pain Award @ Harvard Medical School.
Ajay Garg Ajay Garg has nothing to disclose.
Abby Scurfield, MD Miss Scurfield has nothing to disclose.
Deborah M. Miller, PhD Dr. Miller has received intellectual property interests from a discovery or technology relating to health care.
Susan M. Maixner, MD An immediate family member of Dr. Maixner has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Law office .
Emily Pelc Ms. Pelc has nothing to disclose.
Nadia McMillan, MD, PhD Dr. McMillan has nothing to disclose.
Ribal Najib Haddad, MD Dr. Haddad has nothing to disclose.
Ayesha Ali, MD Dr. Ali has nothing to disclose.
Carmen Calles, MD Dr. Calles has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi, Biogen, Roche, Teva, Novartis, Merck. Dr. Calles has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi, Teva, Biogen, Roche, Novartis, Merck.
Seema Balasubramaniam, MBBS Dr. Balasubramaniam has nothing to disclose.
William Bingaman William Bingaman has nothing to disclose.
David Bruckman David Bruckman has nothing to disclose.
Ian Zhang Ian Zhang has received personal compensation for serving as an employee of Sunovion Pharmaceuticals Inc..
Amanda Reyes, MD Dr. Reyes has nothing to disclose.
Sabrina Ashley Mann Ms. Mann has nothing to disclose.
Leticia Lenkiu Ms. Lenkiu has received personal compensation for serving as an employee of Hesperos inc`.
Sven G. Meuth Sven G. Meuth has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Merck. Sven G. Meuth has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novartis. Sven G. Meuth has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Almirall. Sven G. Meuth has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Celgene. Sven G. Meuth has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genzyme. Sven G. Meuth has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Sven G. Meuth has received personal compensation in the range of $500-$4,999 for serving as a Consultant for TEVA. Sven G. Meuth has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche.
Piyali Chatterjee Piyali Chatterjee has nothing to disclose.
Jacob Alexander Sloane, MD, PhD Dr. Sloane has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for biogen. Dr. Sloane has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech. Dr. Sloane has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi.
Fabian H. Rossi, MD Dr. Rossi has nothing to disclose.
M. Samy Abdullah, MD Dr. Abdullah has nothing to disclose.
Brendan Huang, MD Dr. Huang has nothing to disclose.
Paloma López-Laiz Miss López-Laiz has received personal compensation for serving as an employee of Roche Farma España.
Muhammad Aemaz Ur Rehman, MD Mr. Aemaz Ur Rehman has nothing to disclose.
Chiara Casiglia, Other Mrs. Casiglia has nothing to disclose.
David Bar-Or David Bar-Or has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for Ampio Pharmaceuticals. David Bar-Or has stock in Ampio Pharmaceuticals.
Shelley R. Waite, MD Dr. Waite has nothing to disclose.
Ryan Chapman, MD Dr. Chapman has nothing to disclose.
Laurie Batchelder, PhD Dr. Batchelder has received personal compensation for serving as an employee of IQVIA.
Milena Anatchkova, PhD Dr. Anatchkova has received personal compensation for serving as an employee of Evidera.
Jeff Kraakevik, MD, FAAN The institution of Dr. Kraakevik has received research support from Parkinson Foundation.
Vanessa Di Felice, MD, MPH Dr. Di Felice has received personal compensation for serving as an employee of Genentech.
Solomon Neba Ambe, MBBS Dr. Ambe has nothing to disclose.
Worrawat Engchuan, PhD Dr. Engchuan has nothing to disclose.
Giovanna Franca Fanelli, MD Dr. Fanelli has nothing to disclose.
Juan Manuel Iglesias Passada Mr. Iglesias Passada has nothing to disclose.
Mónica Borges Guerra, Other Mrs. Borges Guerra has nothing to disclose.
Afshin Saffari, MD Dr. Saffari has nothing to disclose.
May Han, MD Dr. Han has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Han has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Arena Pharmaceuticals.
Takanori Hashizume, PhD Prof. Hashizume has nothing to disclose.
Diana Narváez Diana Narváez, 9920 has nothing to disclose.
Karin Woodman, MD Dr. Woodman has nothing to disclose.
Alexander Brown, MD Dr. Brown has nothing to disclose.
Stephanye Argentina Rodriguez Miss Rodriguez has nothing to disclose.
Ram Mohan R. Sankaraneni, MD, FANA, FAES, FAAN Dr. Sankaraneni has nothing to disclose.
Marc Alain Babi, MD Dr. Babi has nothing to disclose.
Soon-Tae Lee, MD, PhD Prof. Lee has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Advanced Neural Technologies. Prof. Lee has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche/Genentech. Prof. Lee has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Celltrion. The institution of Prof. Lee has received research support from Roche. The institution of Prof. Lee has received research support from Autoimmune Encephalitis Alliance. The institution of Prof. Lee has received research support from Celltrion. Prof. Lee has received intellectual property interests from a discovery or technology relating to health care.
Jennifer Frederick Jennifer Frederick has received personal compensation for serving as an employee of Vindico Medical Education.
Masamichi Yokokura, MD,PhD Dr. Yokokura has nothing to disclose.
Howard J. Rosen, MD Dr. Rosen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eisai Pharmaceuticals. Dr. Rosen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech. The institution of Dr. Rosen has received research support from NIH. The institution of Dr. Rosen has received research support from State of CA. Dr. Rosen has a non-compensated relationship as a Consultant with Alector that is relevant to AAN interests or activities. Dr. Rosen has a non-compensated relationship as a Consultant with Prevail Therapeutics that is relevant to AAN interests or activities. Dr. Rosen has a non-compensated relationship as a consultant with Alchemab that is relevant to AAN interests or activities.
Roozbeh Manshaei, PhD Dr. Manshaei has nothing to disclose.
Orlando Garcea Orlando Garcea has nothing to disclose.
Adam Kirton, MD Dr. Kirton has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Multiple. The institution of Dr. Kirton has received research support from Multiple.
Thomas Medina No disclosure on file
Michaela Morris Ms. Morris has nothing to disclose.
Bhooma Thiruv, Other Ms. Thiruv has nothing to disclose.
Ventaka Bendi, MBBS Dr. Bendi has nothing to disclose.
Adam Staffaroni Adam Staffaroni has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alector. Adam Staffaroni has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Passage Bio. Adam Staffaroni has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Takeda. Adam Staffaroni has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Lilly/Prevail. The institution of Adam Staffaroni has received research support from Larry L. Hillblom Foundation. The institution of Adam Staffaroni has received research support from NIA/NIH. The institution of Adam Staffaroni has received research support from Bluefield Project to Cure FTD. Adam Staffaroni has received personal compensation in the range of $0-$499 for serving as a Scientific Review Board with Alzheimer's Drug Discovery Foundation. Adam Staffaroni has received personal compensation in the range of $0-$499 for serving as a Inventor/Holder of Task License with Datacubed Health.
Alicia S. Parker, MD An immediate family member of Dr. Parker has received personal compensation in the range of $5,000-$9,999 for serving as an officer or member of the Board of Directors for Sanara Med Tech. An immediate family member of Dr. Parker has stock in Sanara Med Tech. An immediate family member of Dr. Parker has stock in Rochal Industries. An immediate family member of Dr. Parker has stock in Rochal Parnters. The institution of Dr. Parker has received research support from Texas Alzheimer's Research and Care Consortium. The institution of an immediate family member of Dr. Parker has received research support from Rochal Industries. An immediate family member of Dr. Parker has received intellectual property interests from a discovery or technology relating to health care.
Tammy L. Smith, MD, PhD The institution of Dr. Smith has received research support from Alexion/AstraZeneca. Dr. Smith has a non-compensated relationship as a participant with Euroimmun Academy, receiving travel support to attend, that is relevant to AAN interests or activities.
Ivana Vodopivec, MD Dr. Vodopivec has received personal compensation for serving as an employee of Roche. An immediate family member of Dr. Vodopivec has received personal compensation for serving as an employee of Novartis. Dr. Vodopivec has stock in Roche.
Nicholas Wenz, Other Mr. Wenz has nothing to disclose.
Tresa McGranahan, MD Dr. McGranahan has nothing to disclose.
Sheena K. Aurora, MD Dr. Aurora has received personal compensation for serving as an employee of Impel Neuropharma. Dr. Aurora has stock in Impel Neurpharma.
Bakhtawar Ahmad, MBBS No disclosure on file
Francisco Barrero-Hernandez, Sr., MD Dr. Barrero-Hernandez has nothing to disclose.
Amber Salter, PhD Dr. Salter has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for American Heart Association.
Robert A. Rook Mr. Rook has nothing to disclose.
Hilary Heuer No disclosure on file
Jose Jesus Flores-Rivera, MD Dr. Flores-Rivera has nothing to disclose.
Nomazulu Dlamini, MD, MBBS Dr. Dlamini has nothing to disclose.
Tuncay Gunduz, MD Dr. Gunduz has nothing to disclose.
Katleen Chester, Other Dr. Chester has nothing to disclose.
Kathie M. Bishop, PhD Dr. Bishop has received personal compensation for serving as an employee of Acadia Pharmaceuticals. Dr. Bishop has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for DTx Pharma.
Alyssa Bowling Ms. Bowling has received personal compensation for serving as an employee of Sunovion Pharmaceuticals Inc.
Ariadna Gatti Ms. Gatti has nothing to disclose.
Sandhya Vasan, MD The institution of Dr. Vasan has received research support from US Department of Defense.
Sinem-Hilal Oezalp Ms. Oezalp has nothing to disclose.
Chi-Hyeon Yoo, PhD Mr. Yoo has nothing to disclose.
Stewart J. Tepper, MD Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Aeon. Dr. Tepper has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Abbvie. Dr. Tepper has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Amgen. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Aruene. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Atheneum. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Axsome Therapeutics. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Becker Pharmaceutical Consulting. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cleaview Healhcare Partners. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for CoolTech. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for CRG. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Decision Resources. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Defined Health. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for DRG. Dr. Tepper has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Eli Lilly. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for ExpertConnect. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for FCB Health. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Fenix. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for GLG. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Guidepoint Global. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Health Advances. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Health Science Communications. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for HMP Communications. Dr. Tepper has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Impel. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for InteractiveForums. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Keyquest. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Krog and Partners. Dr. Tepper has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Lundbeck. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for M3 Global Research. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Magnolia Innovation. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for MJH Holdings. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neurolief. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for P Value Communications. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Pain Insights Inc. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Palion Medical. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Pulmatrix. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Putnam Associates. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for SAI MedPartners. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Satsuma. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Slingshot Insights. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Spherix Global Insights. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Strategy Inc. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for System Medical Comm. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Taylor and Francis. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Teva. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Theranica. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Trinity Partners. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UnityHA. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for XOC. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Click Therapeutics. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Miravo. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neurofront Therapeutics. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Rehaler. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Synapse Medical Communications. Dr. Tepper has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Pfizer. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alphasights. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Perfood. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for M3 Global Research. Dr. Tepper has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Scilex. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Synapse Medical Communication. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Tegus. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Aeon. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abbvie. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biohaven. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for ClickTherapeutics. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for CoolTech. Dr. Tepper has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Eli Lilly. Dr. Tepper has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lundbeck. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Miravo Healthcare. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Pulmatrix. Dr. Tepper has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Satsuma. Dr. Tepper has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for AbbVie. Dr. Tepper has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Lundbeck. Dr. Tepper has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Pfizer. Dr. Tepper has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Scilex. Dr. Tepper has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Teva. Dr. Tepper has received personal compensation in the range of $5,000-$9,999 for serving as a CME Speaker with Diamond Headache Clinic. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a CME Speaker with Medical Learning Institute Peerview. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a CME Speaker with Medical Education Speakers Network. Dr. Tepper has received personal compensation in the range of $5,000-$9,999 for serving as a CME Speaker with Miller Medical Communications. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a CME Speaker with Physicians' Education Resource. Dr. Tepper has received personal compensation in the range of $5,000-$9,999 for serving as a CME Speaker with WebMD/Medscape. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a CME speaker with American Headache Society. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a CME speaker with Vindico Medical Education. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a CME speaker with HMP Global. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a CMe speaker with Medical Learning Institute Peerview.
Freddy Escobar-Montealegre, MD Dr. Escobar-Montealegre has nothing to disclose.
Ahmed Ibrahim, MBBCH Dr. Ibrahim has nothing to disclose.
Tamara Castillo-Trivino, MD, MAS, FAAN Dr. Castillo-Trivino has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Castillo-Trivino has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Dr. Castillo-Trivino has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Castillo-Trivino has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Castillo-Trivino has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Castillo-Trivino has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Bristol-Myers Squibb. The institution of Dr. Castillo-Trivino has received research support from Basque Government.
Sarah Germaine, DO Dr. Germaine has nothing to disclose.
Carla E. Santiago-Martinez Ms. Santiago-Martinez has nothing to disclose.
Sung-Min Kim, MD,PhD Prof. Kim has received intellectual property interests from a discovery or technology relating to health care.
Maria Laura Saladino Maria Laura Saladino has nothing to disclose.
Jonathan Ratcliff The institution of Dr. Ratcliff has received research support from Nico Corporation. The institution of Dr. Ratcliff has received research support from Sense .
Todd Kunkel, Other Mr. Kunkel has received personal compensation for serving as an employee of Collegium Pharmaceutical . Mr. Kunkel has stock in Collegium .
Zena Azo, Other Miss Azo has nothing to disclose.
Emily Dvorak Ms. Dvorak has nothing to disclose.
Priya Srikanth, Other Mrs. Srikanth has nothing to disclose.
Richard S. Isaacson, MD, FAAN Dr. Isaacson has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Acadia. Dr. Isaacson has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novo Nordisk. The institution of Dr. Isaacson has received research support from National Institutes of Health. The institution of Dr. Isaacson has received research support from Aces for Alzheimer's. The institution of Dr. Isaacson has received research support from BrainMind. Dr. Isaacson has received publishing royalties from a publication relating to health care.
Deja Rose, MD Dr. Rose has nothing to disclose.
Launia White Launia White has nothing to disclose.
Alise Nacson, Other Ms. Nacson has received personal compensation for serving as an employee of Clinical Outcomes Solutions. Ms. Nacson has received personal compensation for serving as an employee of IQVIA.
Vijayshree Yadav, MD, FAAN Dr. Yadav has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen Pharmaceuticals. Dr. Yadav has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bristol Myers Squibb Foundation. Dr. Yadav has received personal compensation in the range of $500-$4,999 for serving as a Consultant for EMD-Serono . The institution of Dr. Yadav has received research support from Department of Veterans Affairs. Dr. Yadav has received research support from NIH. Dr. Yadav has received research support from PCORI. Dr. Yadav has received research support from NMSS. The institution of Dr. Yadav has received research support from Department of Veterans Affairs. The institution of Dr. Yadav has received research support from Tykeson Family Foundation Endowed Professorship.
Ho-Sung Ryu Ho-Sung Ryu has nothing to disclose.
Devon Conway, MD Dr. Conway has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis Pharmaceuticals. Dr. Conway has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Banner Life Sciences. Dr. Conway has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biogen.
Kathy Merlo, Other Mrs. Merlo has nothing to disclose.
Margaret Savage, MD Dr. Savage has nothing to disclose.
Souhel Najjar, MD Dr. Najjar has nothing to disclose.
Roopa Rajan Roopa Rajan has received research support from DBT. Roopa Rajan has received research support from DST-SERB. The institution of Roopa Rajan has received research support from Michael J Fox Foundaton.
Florian Then Bergh, MD Dr. Then Bergh has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Then Bergh has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Dr. Then Bergh has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Then Bergh has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Horizon. Dr. Then Bergh has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB. Dr. Then Bergh has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Actelion. Dr. Then Bergh has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alexion. Dr. Then Bergh has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen. Dr. Then Bergh has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Bayer. Dr. Then Bergh has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Genzyme. Dr. Then Bergh has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. Dr. Then Bergh has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Fresenius. The institution of Dr. Then Bergh has received research support from Actelion. The institution of Dr. Then Bergh has received research support from Novartis. The institution of Dr. Then Bergh has received research support from DFG (German Science Fund). Dr. Then Bergh has received personal compensation in the range of $10,000-$49,999 for serving as a Member of the Institutional Ethics Board with University of Leipzig, Medical Faculty.
Carolina Ramírez Gómez Carolina Ramírez Gómez has nothing to disclose.
Aakash Shantharam Shetty, MD Dr. Shetty has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abbvie.
Lisa Lohmann Lisa Lohmann has nothing to disclose.
Lakecia Vincent Mrs. Vincent has nothing to disclose.
Stephane Regnier, PhD Mr. Regnier has received personal compensation for serving as an employee of Lundbeck. Mr. Regnier has received personal compensation for serving as an employee of Novartis. Mr. Regnier has stock in Novartis.
Sun Ju Chung, MD, PhD, FAAN Dr. Chung has nothing to disclose.
David Jason McCracken, MD Dr. McCracken has received personal compensation for serving as an employee of GT Medical. Dr. McCracken has received personal compensation in the range of $500-$4,999 for serving as a Consultant for GT Medical. Dr. McCracken has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for GT Medical.
Sharon Scarbro Ms. Scarbro has nothing to disclose.
Ramon Flores-Gonzalez, MD Dr. Flores-Gonzalez has nothing to disclose.
Murat Kurtuncu, MD Dr. Kurtuncu has nothing to disclose.
Loana De Los Santos, Jr., Other Mrs. De Los Santos has nothing to disclose.
Elena Shanina, MD, FAAN Dr. Shanina has nothing to disclose.
Kenneth Stuart Lee, MD Dr. Lee has received personal compensation in the range of $500-$4,999 for serving as a Consultant for GT Medical. Dr. Lee has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novocure. Dr. Lee has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for GT Medical. Dr. Lee has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Huff Powell Bailey Law Firm. An immediate family member of Dr. Lee has stock in Remedy Pharmaceuticals. An immediate family member of Dr. Lee has stock in Martin Pharmaceuticals. An immediate family member of Dr. Lee has stock in Critical Diagnostics. An immediate family member of Dr. Lee has stock in Woolsey Pharmaceuticals. An immediate family member of Dr. Lee has stock in Monogram Orthopaedics. An immediate family member of Dr. Lee has stock in Cytonics. An immediate family member of Dr. Lee has stock in 20-20 Gene Systems.
Fernando Cavalcanti de Falcão Mr. Falcão has nothing to disclose.
Anne Kawamura, MD Dr. Kawamura has nothing to disclose.
Deniz Agirbaslo, MD,PhD Dr. Agirbaslo has nothing to disclose.
Srdjan Stankovic Srdjan Stankovic has received personal compensation for serving as an employee of ACADIA Pharmaceuticals, Inc.. Srdjan Stankovic has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for Neurogene Inc.. Srdjan Stankovic has stock in ACADIA Pharmaceuticals, Inc.. Srdjan Stankovic has stock in Neurogene, Inc..
Daisy Marie Martinez Ms. Martinez has received personal compensation for serving as an employee of Hesperos Inc.
Paolo Preziosa Mr. Preziosa has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Bristol Myers Squibb . Mr. Preziosa has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sanofi Genzyme. Mr. Preziosa has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Mr. Preziosa has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. Mr. Preziosa has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Merck.
Michael Basso, PhD Dr. Basso has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Taylor and Francis.
Piotr Tekiela, MD Dr. Tekiela has nothing to disclose.
Shervin Gholizadeh Mr. Gholizadeh has received personal compensation for serving as an employee of Genentech.
Anthony E. Lang, MD, FAAN Dr. Lang has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Abbvie, Acorda, AFFiRis, Biogen, Denali, Janssen, Intracellular, Kallyope, Lundbeck, Paladin, Retrophin, Roche, Sun Pharma, Theravance, and Corticobasal Degeneration Solutions, Sun Pharma, Medichem, Medtronic, AbbVie and Sunovion. The institution of Dr. Lang has received research support from AbbVie. Dr. Lang has received publishing royalties from a publication relating to health care.
Lya Moore Marques, MD Dr. Marques has nothing to disclose.
Michael Chladek, PhD Dr. Chladek has received personal compensation for serving as an employee of IQVIA. Dr. Chladek has received personal compensation for serving as an employee of Clinical Outcomes Solutions.
Elizabeth Gilley, Other Mrs. Gilley has nothing to disclose.
Maike Schlingmann No disclosure on file
Egilius L H Spierings, MD,PhD Dr. Spierings has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Manistee. Dr. Spierings has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Lundbeck. Dr. Spierings has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Lilly. Dr. Spierings has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Abbvie.
Valory Pavlik, PhD Dr. Pavlik has nothing to disclose.
Vikram Jakkamsetti, MD, PhD, MBBS, CNA Dr. Jakkamsetti has nothing to disclose.
Marco Cursi Marco Cursi has nothing to disclose.
Sarah Marmol, MD Dr. Marmol has nothing to disclose.
Jesus Manuel Martin Martinez Jesus Manuel Martin Martinez has nothing to disclose.
Robert Esgro Robert Esgro has nothing to disclose.
Barbara Eizaguirre Barbara Eizaguirre has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Sanofi Genzyme Argenina. Barbara Eizaguirre has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Roche Argentina. Barbara Eizaguirre has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Roche. Barbara Eizaguirre has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Merck.
Val John Lowe, MD Dr. Lowe has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for AVID Radiopharmaceutical. Dr. Lowe has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eisai Inc. The institution of Dr. Lowe has received research support from AVID Radiopharmaceuticals.
Michela Leocadi, MSc Dr. Leocadi has nothing to disclose.
Maria Sol Román Maria Sol Román has nothing to disclose.
Anandraj Kanwar, MD Dr. Kanwar has nothing to disclose.
Sonya Grace Wang, MD Dr. Wang has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Ovid Therapeutics.
Jessica Sanders, MD The institution of Dr. Sanders has received research support from Autism Intervention Research Network on Physical Health. The institution of Dr. Sanders has received research support from Accreditation Council for Graduate Medical Education.
Benjamin Joseph Osborne, MD, FAAN Dr. Osborne has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Alexion. Dr. Osborne has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biogen. Dr. Osborne has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Bristol Myer Squibb. Dr. Osborne has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Horizon. Dr. Osborne has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Peter Angelos Law Firm. Dr. Osborne has received publishing royalties from a publication relating to health care.
Damiano Mistri, MSC Mr. Mistri has nothing to disclose.
Teresita Corona Vazquez No disclosure on file
Ismail Mohammed Fahad, MBBS Dr. Fahad has nothing to disclose.
Terrie Livingston, PharmD Ms. Livingston has received personal compensation for serving as an employee of EMD Serono, Inc. Ms. Livingston has stock in EMD Serono, Inc. Ms. Livingston has stock in Biogen.
Camila Narvaez Caicedo, MD Dr. Narvaez Caicedo has nothing to disclose.
Ilana Green, MD Dr. Green has nothing to disclose.
Hannah Hanson Hannah Hanson has received personal compensation for serving as an employee of Hesperos.
Giuseppe Magnani Giuseppe Magnani has nothing to disclose.
Gabaldon Torres Laura, Jr., Other Mrs. Laura has nothing to disclose.
Zahid Latif No disclosure on file
Christian Geis Christian Geis has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion, Roche. Christian Geis has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion, Roche, Sobi.
Eleni Antzoulatos, MD Dr. Antzoulatos has nothing to disclose.
Edward D. Huey No disclosure on file
Roger Cady, MD Dr. Cady has received personal compensation for serving as an employee of Lundbeck. Dr. Cady has stock in Alder Biopharmaceutical.
Roberta Lanzillo Roberta Lanzillo has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck, Biogen. Roberta Lanzillo has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen, Roche, Novartis.
Detlef Albrecht Detlef Albrecht has received personal compensation for serving as an employee of Satsuma. Detlef Albrecht has stock in Satsuma.
Julien Cavanagh, MD Dr. Cavanagh has nothing to disclose.
Daniel Ontaneda, MD, PhD, FAAN Dr. Ontaneda has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Ontaneda has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech/Roche. Dr. Ontaneda has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen Idec. Dr. Ontaneda has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech/Roche. The institution of Dr. Ontaneda has received research support from NIH. The institution of Dr. Ontaneda has received research support from PCORI. The institution of Dr. Ontaneda has received research support from NMSS. The institution of Dr. Ontaneda has received research support from Genetech.
Divya M. Radhakrishnan, MD, DM Neurology Dr. Radhakrishnan has received research support from Indian Council of Medical Research, New Delhi, India. Dr. Radhakrishnan has received research support from World Federation of Neurology .
Jordan Gregory Gates, DO Dr. Gates has nothing to disclose.
Jennifer Hislop, MD Dr. Hislop has nothing to disclose.
Miguel Alexis Garcia Sarreon, MD Dr. Garcia Sarreon has nothing to disclose.
Daniel Glaze, MD Dr. Glaze has nothing to disclose.
Xenia Hamann, MD Dr. Hamann has received personal compensation for serving as an employee of Teva GmbH.
Sven Oliver Jarius, MD Dr. Jarius has nothing to disclose.
Klemens Ruprecht, MD Dr. Ruprecht has received research support from European Union (821283-2). Dr. Ruprecht has received research support from Merck Serono. Dr. Ruprecht has received research support from Stiftung Charite. Dr. Ruprecht has received research support from Arthur Arnstein Foundation. Dr. Ruprecht has received publishing royalties from a publication relating to health care.
William G. Ondo, MD Dr. Ondo has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Cerevel. Dr. Ondo has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Supernus. Dr. Ondo has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amneal. Dr. Ondo has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ipsen. Dr. Ondo has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for BlueRock. Dr. Ondo has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Neurocrine. Dr. Ondo has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for ACADIA. Dr. Ondo has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Allergan. Dr. Ondo has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Kyowa Kirin. The institution of Dr. Ondo has received research support from Cerevel. The institution of Dr. Ondo has received research support from Sun. The institution of Dr. Ondo has received research support from SCION. The institution of Dr. Ondo has received research support from Harmony. Dr. Ondo has received publishing royalties from a publication relating to health care.
Shireen Khan, MD Dr. Khan has nothing to disclose.
Subapriya R, MD Dr. R has nothing to disclose.
Sebnem Nash, NP Ms. Nash has nothing to disclose.
Taha Qarni, MD Dr. Qarni has nothing to disclose.
Guillermo Ruben Delgado-Garcia, MD, MSc Dr. Delgado-Garcia has received research support from Consejo Nacional de Ciencia y Tecnologia (Mexico). Dr. Delgado-Garcia has received research support from Consejo Nacional de Ciencia y Tecnologia (Mexico). Dr. Delgado-Garcia has a non-compensated relationship as a Editorial Team Member with Neurology Resident & Fellow Section that is relevant to AAN interests or activities. Dr. Delgado-Garcia has a non-compensated relationship as a Editorial Board Member with Brain and Life en Espanol that is relevant to AAN interests or activities. Dr. Delgado-Garcia has a non-compensated relationship as a Editorial Board Member with Neurology Clinical Practice that is relevant to AAN interests or activities.
Ka-Ho Wong The institution of Mr. Wong has received research support from The Sumaira Foundation .
Mirjon Bishja, MD Dr. Bishja has nothing to disclose.
Xavier Laucirica, MD Dr. Laucirica has nothing to disclose.
Varaporn Unsombut No disclosure on file
Fabián Cortés Fabián Cortés has nothing to disclose.
Christina Massrey, MD Dr. Massrey has nothing to disclose.
Nicole Caunt, DO Dr. Caunt has nothing to disclose.
Suteeraporn Pinyakorn Miss Pinyakorn has nothing to disclose.
Ahsan Moosa Naduvil Valappil, MD Dr. Naduvil Valappil has nothing to disclose.
Klara Mayer No disclosure on file
Darius Ebrahimi-Fakhari, MD, PhD Dr. Ebrahimi-Fakhari has received personal compensation in the range of $0-$499 for serving as a Consultant for Alcimed Inc.. The institution of Dr. Ebrahimi-Fakhari has received research support from CureAP4 Foundation, CureSPG50 Foundation, Spastic Paraplegia Foundation, Manton Center for Orphan Disease Research, BPAN Warriors Foundation, NIH/NINDS. Dr. Ebrahimi-Fakhari has received publishing royalties from a publication relating to health care.
Kelsey Carolyn Hillhouse, MD Dr. Carr has nothing to disclose.
Emily Scully Mrs. Scully has nothing to disclose.
Phillip Chan No disclosure on file
Elise Ruth Hennessy, MD Dr. Hennessy has nothing to disclose.
Jessica Ann Sagen Ms. Sagen has nothing to disclose.
Jeffrey Scott Bishop, PA Mr. BISHOP has nothing to disclose.
Patrick J. Cimino No disclosure on file
Rocío Gómez, Other Ms. Gómez has received personal compensation for serving as an employee of Roche Farma Spain, Medical Department.
Muhammad Faraz Raghib, MD Dr. Raghib has nothing to disclose.
Joe Andrew Whitney, Other Mr. Whitney has nothing to disclose.
Jorge Luis Morales, MD Dr. Morales has nothing to disclose.
Andy Yu-Der Wang, MD Mr. Wang has nothing to disclose.
Tatevik Mazmanyan, Other Miss Mazmanyan has nothing to disclose.
Yumiko Okahashi, MD, PhD Dr. Okahashi has nothing to disclose.
Guilherme Diogo Silva, MD Dr. SILVA has nothing to disclose.
Yasuomi Ouchi, MD,PhD The institution of Prof. Ouchi has received research support from Sumitomo Pharma Co., Ltd.
Anish Bhardwaj, MD, FAHA, FCCM, FAAN Dr. Bhardwaj has nothing to disclose.
Dewei She Dewei She has received personal compensation for serving as an employee of Horizon Therapeutics.
Kathryn Holroyd, MD Dr. Holroyd has nothing to disclose.
Kevin Michael Nelson Mr. Nelson has nothing to disclose.
Robert Kadish, MD Dr. Kadish has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. The institution of Dr. Kadish has received research support from Alexion Pharmaceuticals.
Christopher Hemond, MD Dr. Hemond has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for VIVIO Health. Dr. Hemond has stock in VIVIO Health. The institution of Dr. Hemond has received research support from Consorium of Multiple Sclerosis Centers. The institution of Dr. Hemond has received research support from National Multiple Sclerosis Society. The institution of Dr. Hemond has received research support from National Center for Advancing Translational Sciences, National Institutes of Health. The institution of Dr. Hemond has received research support from University of Massachusetts Memorial Medical Center. The institution of Dr. Hemond has received research support from National Institute Of Neurological Disorders And Stroke of the National Institutes of Health. Dr. Hemond has received personal compensation in the range of $0-$499 for serving as a Member of Data Safety and Monitoring Board with National Institute Of Neurological Disorders And Stroke of the National Institutes of Health.
Muhammad Qasim Qureshi Mr. Qureshi has nothing to disclose.
Zbigniew K. Wszolek, MD, FAAN Dr. Wszolek has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Polish Neurological Society/Via Medica.
Elizabeth Piette, PhD Dr. Piette has received personal compensation for serving as an employee of EMD Serono, Inc. An immediate family member of Dr. Piette has received personal compensation for serving as an employee of OnCorps. An immediate family member of Dr. Piette has received personal compensation for serving as an employee of Exosome Diagnostics.
Virginia M. Smith, PhD Dr. Smith has stock in Hesperos, Inc..
Louis Cappelli, DO Dr. Cappelli has nothing to disclose.
Roberto Santangelo Roberto Santangelo, 4503 has nothing to disclose.
Stephen W. Scherer, PhD Dr. Scherer has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Population Bio. Dr. Scherer has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Nature-Springer. The institution of Dr. Scherer has received research support from Autism Speaks. The institution of Dr. Scherer has received research support from Genome Canada. The institution of Dr. Scherer has received research support from SFARI. The institution of Dr. Scherer has received research support from CIHR. The institution of Dr. Scherer has received research support from NIH. The institution of Dr. Scherer has received research support from Qatar National Research Fund. The institution of Dr. Scherer has received research support from Ontario Brain Institute. The institution of Dr. Scherer has received research support from Canada's Digital Technology Supercluster. The institution of Dr. Scherer has received research support from Canada Foundation for Innovation. The institution of Dr. Scherer has received research support from Ontario Research Fund. Dr. Scherer has received intellectual property interests from a discovery or technology relating to health care. Dr. Scherer has received personal compensation in the range of $10,000-$49,999 for serving as a Highly Cited Academic Research Program with King Abdullaziz University.
Sandra Vanotti Sandra Vanotti has nothing to disclose.
Knarik Arkun Knarik Arkun has nothing to disclose.
Nick Corriveau-Lecavalier, PhD Dr. Corriveau-Lecavalier has nothing to disclose.
Avi Landman, MD Dr. Landman has nothing to disclose.
Kon Chu, MD, PhD Prof. Chu has nothing to disclose.
Sara Terrim, MD Dr. Terrim has nothing to disclose.
Walter Kremers The institution of Walter Kremers has received research support from Biogen.
Sherry Harlass, Other Mrs. Harlass has received personal compensation for serving as an employee of FTD Disorders Registry LLC.
Rutaab Kareem Ms. Kareem has nothing to disclose.
Christoph Kleinschnitz, MD Dr. Kleinschnitz has nothing to disclose.
Shawn Alter, PhD Dr. Alter has received personal compensation for serving as an employee of Axsome Therapeutics. Dr. Alter has stock in Axsome Therapeutics.
Michael R. Yeaman, PhD Dr. Yeaman has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Yeaman has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Genentech-Roche. Dr. Yeaman has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alexion. The institution of Dr. Yeaman has received research support from National Institutes of Health. The institution of Dr. Yeaman has received research support from U.S. Department of Defense. Dr. Yeaman has received intellectual property interests from a discovery or technology relating to health care. Dr. Yeaman has received intellectual property interests from a discovery or technology relating to health care.
Zachariah Thomas Zachariah Thomas has received personal compensation for serving as an employee of Axsome. Zachariah Thomas has stock in Axsome .
Melissa Ann Wright, MD Dr. Wright has nothing to disclose.
Susan W. Law, DO Dr. Law has nothing to disclose.
Matt *Use 378374 Kennis, Other Mr. Kennis has received personal compensation for serving as an employee of Neurocrine Biosciences.
Ryan Miller, MD Dr. Miller has nothing to disclose.
Lara Bardoneschi, Other Miss Bardoneschi has nothing to disclose.
Alok Dabi, MD, MBBS Dr. Dabi has nothing to disclose.
Tjalf Ziemssen, MD, FAAN Dr. Ziemssen has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. Dr. Ziemssen has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Roche. Dr. Ziemssen has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis. Dr. Ziemssen has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for BMS Celgene. Dr. Ziemssen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Dr. Ziemssen has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. Dr. Ziemssen has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Dr. Ziemssen has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Merck. Dr. Ziemssen has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Sanofi. Dr. Ziemssen has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for BMS Celgene. Dr. Ziemssen has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen. Dr. Ziemssen has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for TEVA. The institution of Dr. Ziemssen has received research support from Biogen. The institution of Dr. Ziemssen has received research support from Novartis. The institution of Dr. Ziemssen has received research support from Merck. The institution of Dr. Ziemssen has received research support from Sanofi. The institution of Dr. Ziemssen has received research support from Celgene.
Lars Neeb Dr. Neeb has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis, Lilly, TEVA, Hormosan. Dr. Neeb has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis, Lilly, TEVA, BIAL, Hormosan, Allergan.
Zach Cramer Mr. Cramer has nothing to disclose.
Michael Levy, MD, PhD, FAAN Dr. Levy has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Mitsubishi Pharma. Dr. Levy has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB Pharma. Dr. Levy has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi. Dr. Levy has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Levy has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Horizon. Dr. Levy has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Levy has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier. Dr. Levy has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Various law firms. The institution of Dr. Levy has received research support from National Institutes Health.
Stuart H. Isaacson, MD, FAAN The institution of Dr. Isaacson has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Acadia. The institution of Dr. Isaacson has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sunovion. The institution of Dr. Isaacson has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for acorda. The institution of Dr. Isaacson has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Supernus. The institution of Dr. Isaacson has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Neurocrine. The institution of Dr. Isaacson has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Kyowa. The institution of Dr. Isaacson has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for adamas. The institution of Dr. Isaacson has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Lundbeck. The institution of Dr. Isaacson has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Teva. The institution of Dr. Isaacson has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Neuroderm. The institution of Dr. Isaacson has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Abbvie. The institution of Dr. Isaacson has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for amneal. Dr. Isaacson has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Teva. Dr. Isaacson has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Neurocrine. Dr. Isaacson has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for adamas. Dr. Isaacson has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Lundbeck. Dr. Isaacson has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Supernus. Dr. Isaacson has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Acadia. Dr. Isaacson has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Acorda. Dr. Isaacson has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Amneal. Dr. Isaacson has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Abbvie.
Robert Allan Corns, PhD Dr. Corns has nothing to disclose.
Hsiao-Ying Monica Wey, PhD Prof. Wey has nothing to disclose.
Richard Gregory Boles, MD Dr. Boles has received personal compensation in the range of $50,000-$99,999 for serving as an officer or member of the Board of Directors for NeuroNeeds . Dr. Boles has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Mitochondrial and Molecular Medicine. Dr. Boles has stock in NeuroNeeds.
Mehmet Seven, MD Prof. Seven has nothing to disclose.
Charles Ruetsch, PhD The institution of Dr. Ruetsch has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Otsuka Amrerica. The institution of Dr. Ruetsch has received research support from Otsuka America. The institution of Dr. Ruetsch has received research support from Acadia. The institution of Dr. Ruetsch has received research support from Atentiv. The institution of Dr. Ruetsch has received research support from GSK. The institution of Dr. Ruetsch has received research support from Medtronic. The institution of Dr. Ruetsch has received research support from Novartis. The institution of Dr. Ruetsch has received research support from Orexo.
Francesco Patti, MD Dr. Patti has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion, Almirall, Bayer, Biogen, Bristol Meyers and Squibb Merck, Roche, Sanofi, TEVA. Dr. Patti has received personal compensation in the range of $500-$4,999 for serving as an officer or member of the Board of Directors for University of Catania and AISM/FISM, Fondazione Italiana Sclerosi Multipla.
Clara Ferreira, PhD Dr. Ferreira has nothing to disclose.
Jonathan Charlesworth, PhD Dr. Charlesworth has received personal compensation for serving as an employee of Noctrix Health, Inc.. Dr. Charlesworth has stock in Noctrix Health, Inc.. The institution of Dr. Charlesworth has received research support from NIH (NINDS). Dr. Charlesworth has received intellectual property interests from a discovery or technology relating to health care.
Rajesh K. Gupta, MBBS Dr. Gupta has nothing to disclose.
Prakroothi Surendra Danthi, Other Mrs. Danthi has nothing to disclose.
Elina Misicka, PhD Dr. Misicka has nothing to disclose.
Omri Bar Mr. Bar has nothing to disclose.
Leonardo Aguilar-Gonzalez, PhD Dr. Aguilar-Gonzalez has nothing to disclose.
Timothy Feyma, MD Dr. Feyma has received personal compensation in the range of $500-$4,999 for serving as a Consultant for PTC Therapeutics. Dr. Feyma has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for PTC Therapeutics.
Vaidehi Bhavaraju Miss Bhavaraju has nothing to disclose.
Jalon Chambers, Other Mr. Chambers has nothing to disclose.
Berenice Silva SIlva Berenice has nothing to disclose.
Fanyang Zeng Ms. Zeng has received personal compensation for serving as an employee of Evidera.
Saul Reyes, MD Dr. Reyes has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Dr. Reyes has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Reyes has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for BIIB. Dr. Reyes has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Merck. Dr. Reyes has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Novartis. Dr. Reyes has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Biogen.
Rosario Blasco Quilez Rosario Blasco Quilez has nothing to disclose.
Ada Breitenbucher, MD Dr. Breitenbucher has nothing to disclose.
Carolyn Pasifull Hunt, MD Dr. Hunt has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Borden Ladner Gervais.
Amitha Ananth, MD Dr. Ananth has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Reata Therapeutics. The institution of Dr. Ananth has received research support from Acadia Pharmaceuticals.
Adam Uppendahl Mr. Uppendahl has nothing to disclose.
Mariona Hervas Pujol Mariona Hervas Pujol has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi, Merk, Bayer, Biogen, Almirall.
Neal Sondheimer, MD Dr. Sondheimer has received personal compensation for serving as an employee of Synlogic. Dr. Sondheimer has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Science Advances.
Natalia Ciufia, Sr., Other Miss Ciufia has nothing to disclose.
Katelyn Costanza Ms. Costanza has nothing to disclose.
Ross Reichard The institution of Ross Reichard has received research support from NIH. An immediate family member of Ross Reichard has received publishing royalties from a publication relating to health care.
Ralf Gold, MD Dr. Gold has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biogen . Dr. Gold has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis. Dr. Gold has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Roche. Dr. Gold has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genzyme. Dr. Gold has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bayer Vital. Dr. Gold has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eisai Pharamaceuticals. Dr. Gold has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Gold has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Gold has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for SAGE Publishers. Dr. Gold has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Novartis. Dr. Gold has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Biogen. The institution of Dr. Gold has received research support from Novartis. The institution of Dr. Gold has received research support from Biogen.
Cleo Zarina Alejo Reyes, MD Dr. Reyes has nothing to disclose.
Rohan Vikram Patel Mr. Patel has nothing to disclose.
Richard A. Lewis, MD, FAAN Dr. Lewis has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Argenx. Dr. Lewis has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for CSL Behring. Dr. Lewis has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi. Dr. Lewis has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Grifols. Dr. Lewis has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Lewis has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Lewis has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Boehringer Ingralhim. Dr. Lewis has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alnylam. Dr. Lewis has received publishing royalties from a publication relating to health care.
Almira Doreen Abigail Apor, MD Dr. Apor has nothing to disclose.
Barbara Prosser Barbara Prosser has nothing to disclose.
Shruthi Sree Sivakumar, MBBS Dr. Sivakumar has nothing to disclose.
Juliana Lago, Other Mrs. Lago has nothing to disclose.
Matthew Peach, MD,PhD Dr. Peach has nothing to disclose.
Nicole Gidaya Bonine, PhD Mrs. Bonine has received personal compensation for serving as an employee of Genentech. Mrs. Bonine has stock in Genentech.
John Wei Dr. Wei has nothing to disclose.
Bum Joon Kim Dr. Kim has nothing to disclose.
Dylan Franco Del Papa, MD Dr. Del Papa has nothing to disclose.
Irfan Sahail Sheikh, MD Dr. Sheikh has nothing to disclose.
Burkhard Blank Burkhard Blank has received personal compensation for serving as an employee of Acorda Therapeutics. Burkhard Blank has received stock or an ownership interest from Acorda Therapeutics, Inc.
Joachim Hipp, PhD Dr. Hipp has received personal compensation for serving as an employee of Teva.
Faisal Alotaibi Faisal Alotaibi has nothing to disclose.
Gregor Broessner Gregor Broessner has received personal compensation in the range of $0-$499 for serving as a Consultant for Novartis. Gregor Broessner has received personal compensation in the range of $0-$499 for serving as a Consultant for TEVA. Gregor Broessner has received personal compensation in the range of $0-$499 for serving as a Consultant for Lilly. Gregor Broessner has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for TEVA. Gregor Broessner has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for TEVA. Gregor Broessner has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Lilly.
Alan K. Percy, MD, FAAN Dr. Percy has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Acadia Pharmaceuticals. Dr. Percy has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Taysha Gene Therapies. Dr. Percy has received personal compensation in the range of $0-$499 for serving as a Consultant for Neurogene. Dr. Percy has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Taysha Gene Therapies. Dr. Percy has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for IOS Press.
Xianping Li No disclosure on file
Hirotsugu Takashima, MD Dr. Takashima has nothing to disclose.
Ana Margarita Buenfil, Other Ms. Buenfil has received personal compensation for serving as an employee of IQVIA.
John E. Greenlee, MD, FAAN Dr. Greenlee has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Medlink. Dr. Greenlee has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Zeigler Cohen Roche. Dr. Greenlee has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Sommers Schwartz PC. Dr. Greenlee has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for St Francis Hospital. Dr. Greenlee has received publishing royalties from a publication relating to health care. Dr. Greenlee has received publishing royalties from a publication relating to health care.
Jill De Rijke Miss De Rijke has nothing to disclose.
Katrin Giglhuber Katrin Giglhuber has nothing to disclose.
Clark Chen No disclosure on file
Mindy Grall, PhD, NP Ms. Grall has received personal compensation for serving as an employee of Supernus Pharmaceuticals. Ms. Grall has stock in Supernus.
Brett Trost, PhD Dr. Trost has nothing to disclose.
Amanda Breaux, MD Dr. Breaux has nothing to disclose.
Muhammad Abbas Khokhar, MBBS,MD Dr. Khokhar has nothing to disclose.
Herriot Tabuteau, MD Dr. Tabuteau has received personal compensation for serving as an employee of Axsome Therapeutics. Dr. Tabuteau has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for Axsome Therapeutics. Dr. Tabuteau has received stock or an ownership interest from Axsome Therapeutics. Dr. Tabuteau has received intellectual property interests from a discovery or technology relating to health care.
Achim Berthele Achim Berthele has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Achim Berthele has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Bayer. Achim Berthele has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Celgene. Achim Berthele has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Achim Berthele has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Achim Berthele has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Achim Berthele has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Achim Berthele has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen. Achim Berthele has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alexion.
Mancia M. Ko, Other Dr. Ko has received personal compensation for serving as an employee of Collegium Pharmaceutical.
Daniela Sofia Rodriguez Ms. Rodriguez has nothing to disclose.
Jacob Rube, MD Dr. Rube has nothing to disclose.
Alan Jeffrey Cohen, MD Dr. Cohen has nothing to disclose.
James J. Hickman, PhD Dr. Hickman has stock in Hesperos, Inc. Dr. Hickman has received research support from Hesperos, Inc.
Allison Nancy Kayne Ms. Kayne has nothing to disclose.
Thy Nguyen, MD Dr. Nguyen has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for ArgenX. Dr. Nguyen has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for UCB. Dr. Nguyen has received publishing royalties from a publication relating to health care.
Laura Andrea Serna Miss Serna has nothing to disclose.
Ashley Santilli, MD Dr. Santilli has nothing to disclose.
Kristina Rae Patterson, MD, PhD Dr. Patterson has received personal compensation for serving as an employee of Hospital of the University of Pennsylvania. Dr. Patterson has stock in Horizon Therapeutics.
Anna McCormick, MD The institution of Dr. MCCORMICK has received research support from Ontario Brain Institute. The institution of Dr. MCCORMICK has received research support from Brain Canada .
Jose Avila-Ornelas, MD Dr. Avila-Ornelas has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bristol Myers Squib. Dr. Avila-Ornelas has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Avila-Ornelas has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech. An immediate family member of Dr. Avila-Ornelas has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech. Dr. Avila-Ornelas has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Horizon. Dr. Avila-Ornelas has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. An immediate family member of Dr. Avila-Ornelas has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Avila-Ornelas has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Avila-Ornelas has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for EMD Serono. An immediate family member of Dr. Avila-Ornelas has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for EMD Serono. An immediate family member of Dr. Avila-Ornelas has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Genzyme. Dr. Avila-Ornelas has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biogen. An immediate family member of Dr. Avila-Ornelas has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biogen. Dr. Avila-Ornelas has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Horizon. Dr. Avila-Ornelas has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Alexion. Dr. Avila-Ornelas has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Banner Pharmaceuticals.
Francesca Caso, MD Dr. Caso has nothing to disclose.
Luisa Maria Marquez Ms. Marquez has nothing to disclose.
Giordano Cecchetti Giordano Cecchetti has nothing to disclose.
Vijay K. Ramanan, MD, PhD The institution of Dr. Ramanan has received research support from the National Institutes of Health. The institution of Dr. Ramanan has received research support from the Mangurian Foundation for Lewy Body Disease Research. The institution of Dr. Ramanan has received research support from as part of clinical trials sponsored by the Alzheimer's Association, Eisai, the Alzheimer's Treatment and Research Institute at USC, and Transposon Therapeutics, Inc.. The institution of Dr. Ramanan has received research support from Medscape. Dr. Ramanan has received personal compensation in the range of $500-$4,999 for serving as a Conference Speaker/Organizer (Honoraria) with AANI.
Jesse Schold, PhD The institution of Dr. Schold has received research support from NIDDK.
Jose Luis Sanchez Menoyo, MD Dr. Sanchez Menoyo has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Dr. Sanchez Menoyo has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi. Dr. Sanchez Menoyo has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Dr. Sanchez Menoyo has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Sanchez Menoyo has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis.
Katya Rascovsky No disclosure on file
Moqing Quan Ms. Quan has nothing to disclose.
Ilya Kister, MD, FAAN Dr. Kister has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Genentech-Roche. Dr. Kister has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Horizon. The institution of Dr. Kister has received research support from Genentech. The institution of Dr. Kister has received research support from Novartis. Dr. Kister has received publishing royalties from a publication relating to health care.
Refik Pul Refik Pul has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion, BMS, Hexal, Horizon, Janssen, Merck, Novartis, Sanofi . Refik Pul has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion, BMS, Hexal, Horizon, Janssen, Merck, Novartis, Sanofi .
Nari Choi Dr. Choi has nothing to disclose.
Felipe Simoes Jones, MD Dr. Simoes Jones has nothing to disclose.
Katinka Fischer Ms. Fischer has nothing to disclose.
Adam D. Lazar, Other Mr. Lazar has nothing to disclose.
Mariana Alexandra Torres, MD Miss TORRES has nothing to disclose.
Diana Wheaton Diana Wheaton has received personal compensation for serving as an employee of FTD Disorders Registry. The institution of Diana Wheaton has received research support from Rainwater Charitable Foundation. The institution of Diana Wheaton has received research support from NIA.
Charly Gaul Dr. Gaul has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Weber & Weber, Lundbeck, and Perfood. Dr. Gaul has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Allergan Pharma, Lilly, Novartis Pharma, Hormosan Pharma, Sanofi-Aventis, Perfood, and TEVA. Dr. Gaul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Allergan Pharma, Lilly, Novartis Pharma, Hormosan Pharma, Grünenthal, Sanofi-Aventis, and TEVA. Dr. Gaul has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for The Journal of Headache and Pain, Acta Neurologica Scandinavia. Dr. Gaul has received publishing royalties from a publication relating to health care. Dr. Gaul has received personal compensation in the range of $0-$499 for serving as a Honorary secretary with German Migraine and Headache Society.
Ping Zhao Ping Zhao has received personal compensation for serving as an employee of Acorda Therapeutics Inc. Ping Zhao has received stock or an ownership interest from Acorda Therapeutics Inc..
Daniel León Tramontini Mr. León Tramontini has nothing to disclose.
Julie A. Fields, PhD The institution of Dr. Fields has received research support from National Institutes of Health. The institution of Dr. Fields has received research support from Patient-Centered Outcomes Research Institute.
Taku Hatano, MD Dr. Hatano has nothing to disclose.
John J. Chen John J. Chen has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for UCB. John J. Chen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. John J. Chen has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Horizon.
Aaron Ross Switzer, MSc Dr. Switzer has nothing to disclose.
Natalie Rene Taylor, Other The institution of Miss Taylor has received research support from Alexion.
Wenyin Shi, MD Dr. Shi has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novocure. Dr. Shi has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for zai lab. Dr. Shi has received personal compensation in the range of $500-$4,999 for serving as a Consultant for varian. Dr. Shi has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for novocure.
Brian Talon, PhD Dr. Talon has nothing to disclose.
Serhat Guler No disclosure on file
Carole Marcillat Carole Marcillat has received personal compensation for serving as an employee of Hoffmann La Roche.
Elisa Schmidt No disclosure on file
Aysel Kalayci Yigin, PhD Dr. Kalayci Yigin has nothing to disclose.
Mirela V. Simon, MD Dr. Simon has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Risk Management Foundation of the Harvard Institutions Incorporated. Dr. Simon has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for MCIC Vermont. Dr. Simon has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Aaronson, Rappaport, Feinstein& Deutch. Dr. Simon has received publishing royalties from a publication relating to health care. Dr. Simon has received personal compensation in the range of $0-$499 for serving as a Speaker with American Clinical Neurophysiology Society . Dr. Simon has a non-compensated relationship as a Speaker with International Society of Intraoperative Neurophysiology that is relevant to AAN interests or activities. Dr. Simon has a non-compensated relationship as a Speaker with Brazilian Congress of Neurology that is relevant to AAN interests or activities.
Sarah Kathryn Lageman, PhD Dr. Lageman has nothing to disclose.
Tyler William Kolander, Other Mr. Kolander has nothing to disclose.
Qasem N. Alshaer, MD Dr. Alshaer has nothing to disclose.
Nidhi Desai Miss Desai has nothing to disclose.
Michael Heckman Michael Heckman has nothing to disclose.
Farren Briggs, PhD The institution of Prof. Briggs has received research support from NIH. The institution of Prof. Briggs has received research support from Michael J. Fox Foundation.
Michael Stagg Chamberlain Mr. Chamberlain has nothing to disclose.
Michael Karenfort, MD Dr. Karenfort has nothing to disclose.
Salman Rashid, MD Dr. Rashid has nothing to disclose.
Steven M. Lazar, MD Dr. Lazar has nothing to disclose.
Majed Alzahrany, MBBS Dr. Alzahrany has nothing to disclose.
Mark Willy Mondia Mark Willy Mondia has nothing to disclose.
Maria Seipelt Maria Seipelt has nothing to disclose.
Karen Ho, MD No disclosure on file
Laura Cacciaguerra, MD, PhD Ms. Cacciaguerra has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Ms. Cacciaguerra has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for BMS Celgene. Ms. Cacciaguerra has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sanofi. Ms. Cacciaguerra has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for BIOMEDIA.
Katie Robinson, PhD Dr. Robinson has nothing to disclose.
Sergio L. Angulo Castro, MD, PhD Dr. Angulo Castro has nothing to disclose.
Maria Assunta Rocca Maria Assunta Rocca has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen, Bristol Myers Squibb, Eli Lilly, Janssen, Roche. Maria Assunta Rocca has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for AstraZaneca, Biogen, Bristol Myers Squibb, Bromatech, Celgene, Genzyme, Horizon Therapeutics Italy, Merck Serono SpA, Novartis, Roche, Sanofi and Teva. The institution of Maria Assunta Rocca has received research support from MS Society of Canada, the Italian Ministry of Health, the Italian Ministry of University and Research, and Fondazione Italiana Sclerosi Multipla.
Renato Puppi Munhoz, MD Dr. Munhoz has nothing to disclose.
Spencer Poiset, MD Dr. Poiset has nothing to disclose.
Marius Ringelstein Marius Ringelstein has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Marius Ringelstein has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion.
Judith Bellmann-Strobl, MD Judith Bellmann-Strobl, MD has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Judith Bellmann-Strobl, MD has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Judith Bellmann-Strobl, MD has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi Genzyme. Judith Bellmann-Strobl, MD has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. The institution of Judith Bellmann-Strobl, MD has received research support from Bayer. The institution of Judith Bellmann-Strobl, MD has received research support from NEMOS.
Xiaoyang Li, MD Dr. Li has nothing to disclose.
Kyle Mahoney, MD The institution of Dr. Mahoney has received research support from Viela Bio.
Matthew McGuinness, MD Dr. McGuinness has nothing to disclose.
Eric Stulberg, MD Dr. Stulberg has nothing to disclose.
Cesar Franco Ruiz, MD Dr. Franco Ruiz has nothing to disclose.
Laura Navarro Laura Navarro has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Laura Navarro has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen idec. Laura Navarro has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi-Genzyme.
Vivien Haeussler, MD Mrs. Haeussler has nothing to disclose.
Pankhuri Banerjee, MBBS Dr. Banerjee has nothing to disclose.
Omar Fatehi Jbarah, MD Dr. Jbarah has nothing to disclose.
Julie Patel, Other Dr. Patel has nothing to disclose.
Christianne Mojica Christianne Mojica has nothing to disclose.
Daniel M. Cimbora, PhD Dr. Cimbora has received personal compensation for serving as an employee of Viela Bio. Dr. Cimbora has received stock or an ownership interest from Viela Bio.
Kaitlin Sovich Ms. Sovich has nothing to disclose.
Hans-Peter Hartung, MD, FAAN Dr. Hartung has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BMS Celgene. Dr. Hartung has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Geneuro. Dr. Hartung has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Hartung has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Hartung has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Dr. Hartung has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Bayer. Dr. Hartung has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TG Therapeutics. Dr. Hartung has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Hartung has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Frontiers Neurology.
Timothy Walton Timothy Walton has nothing to disclose.
Julie Widmar, NP Miss Widmar has nothing to disclose.
Susana Sainz de la Maza Susana Sainz de la Maza has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Almirall, Biogen, Merck, Novartis, Roche and Sanofi-Genzyme.
Richard Marini Richard Marini has received personal compensation for serving as an employee of Acorda Therapeutics. Richard Marini has stock in Acorda Therapeutics.
Rupin Singh, MD Dr. Singh has nothing to disclose.
Ibrahim Ahmad Mr. Ahmad has nothing to disclose.
Isabel Schauerte Dr. Schauerte has stock in Institut Dr. Schauerte GbR. Dr. Schauerte has received personal compensation in the range of $100,000-$499,999 for serving as a COO with Institut Dr. Schauerte GmbH.
Shannon Knights, MD Dr. Knights has nothing to disclose.
Kiara N. Velez, MD No disclosure on file
Matthew Feldman, MD Dr. Feldman has nothing to disclose.
Amanda Kelly Miss Kelly has nothing to disclose.
Mustafa Sahin, MD, PhD Dr. Sahin has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Regenxbio . Dr. Sahin has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Centene. Dr. Sahin has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Celgene. Dr. Sahin has received personal compensation in the range of $500-$4,999 for serving as an officer or member of the Board of Directors for PTEN Research. Dr. Sahin has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier. The institution of Dr. Sahin has received research support from NIH. The institution of Dr. Sahin has received research support from Tuberous Sclerosis Alliance. The institution of Dr. Sahin has received research support from Charities Aid Foundation. The institution of Dr. Sahin has received research support from Simons Foundation Autism Research Initiative. The institution of Dr. Sahin has received research support from Aucta Pharmaceuticals . The institution of Dr. Sahin has received research support from Loulou Foundation.
Adam Connell Kneepkens Mr. Kneepkens has nothing to disclose.
Moath Hamed, MD Dr. Hamed has nothing to disclose.
Piero Barbanti, MD Dr. Barbanti has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abbvie. Dr. Barbanti has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Eli-Lilly. Dr. Barbanti has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TEVA. Dr. Barbanti has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Fondazione Ricerca e Salute. Dr. Barbanti has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lundbeck. Dr. Barbanti has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Visufarma. Dr. Barbanti has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Assosalute. Dr. Barbanti has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Bayer. Dr. Barbanti has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Eli-Lilly. Dr. Barbanti has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Organon. Dr. Barbanti has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Dr. Barbanti has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for TEVA. Dr. Barbanti has received publishing royalties from a publication relating to health care.
Heather Dawn Cannon-Patron, Other Ms. Cannon has received personal compensation for serving as an employee of Hesperos, Inc.. Ms. Cannon has stock in Hesperos, Inc..
Chilvana V. Patel, MBBS, FAAN Dr. Patel has nothing to disclose.
Fabio Minicucci, MD Dr. Minicucci has nothing to disclose.
Dagoberto Callegaro, PhD No disclosure on file
Joseph Francis Imbs, IV, DO Dr. Imbs has nothing to disclose.
Seung Hyun Lee, MD Dr. Lee has nothing to disclose.
Ihika Rampalli Ms. Rampalli has nothing to disclose.
Jonathan Wickel, MD Dr. Wickel has nothing to disclose.
Michael Vincent Robers, MD Dr. Robers has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Robers has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for EMD Serono. The institution of Dr. Robers has received research support from National Multiple Sclerosis Society. The institution of Dr. Robers has received research support from Bristol Myers Squibb Foundation. The institution of Dr. Robers has received research support from Barrow Neurological Foundation.
Erin Dennis, MD Dr. Dennis has nothing to disclose.
Eduardo Aguera Morales, MD, PhD Dr. Aguera Morales has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Dr. Aguera Morales has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis .
Christine Miller, PharmD Christine Miller has nothing to disclose.
Achal K. Srivastava, MD, FAAN Dr. Srivastava has nothing to disclose.
Mahmoud Elkhooly, MD Mr. Elkhooly has nothing to disclose.
Xiaoyu Sun Xiaoyu Sun has received personal compensation for serving as an employee of American Academy of Neurology. An immediate family member of Xiaoyu Sun has received personal compensation for serving as an employee of Syneos Health. An immediate family member of Xiaoyu Sun has stock in Syneos Health. An immediate family member of Xiaoyu Sun has stock in BioNTech.
Florian Nickel Florian Nickel has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Florian Nickel has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Janssen. Florian Nickel has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck Serono. Florian Nickel has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Florian Nickel has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen. Florian Nickel has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for BMS.
Meagan Newell, MD Dr. Newell has nothing to disclose.
Amaal AlDakheel Amaal AlDakheel has nothing to disclose.
Hiroshi Nagayama, MD,PhD Prof. Nagayama has nothing to disclose.
Angelica Carolina Cornejo, MD Dr. Cornejo has nothing to disclose.
Laurie Ebenau, Other Miss Ebenau has nothing to disclose.
Osamu Kano, MD, PhD Dr. Kano has nothing to disclose.
Awadh K. Pandit Awadh K. Pandit has nothing to disclose.
Hongxuyang Yu, MD Dr. Yu has nothing to disclose.
Veit Rothhammer, MD Prof. Rothhammer has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Prof. Rothhammer has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. The institution of Prof. Rothhammer has received research support from German Research Foundation. The institution of Prof. Rothhammer has received research support from European Research Council.
Carolina Restrepo, MD Dr. Restrepo has nothing to disclose.
Yasaman Pirahanchi, MD Dr. Pirahanchi has nothing to disclose.
Jamie C. McDonald, MD Dr. McDonald has nothing to disclose.
Thomas Nalpathamkalam, Jr., Other Mr. Nalpathamkalam has nothing to disclose.
Donald Frei Donald Frei has received personal compensation in the range of $0-$499 for serving as a Consultant for Philips. Donald Frei has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Stryker. Donald Frei has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Siemens. Donald Frei has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Shape Memory Medical. Donald Frei has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Genentech. Donald Frei has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Stryker. Donald Frei has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Penumbra. Donald Frei has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Viz.AI. Donald Frei has received stock or an ownership interest from Penumbra. Donald Frei has received research support from Penumbra.
Kevin Frank Bieniek, PhD Dr. Bieniek has nothing to disclose.
Stuart McCarter, MD Dr. McCarter has nothing to disclose.
Jacinta Behne Ms. Behne has nothing to disclose.
Christine Shrock, MD Dr. Shrock has nothing to disclose.
Ayush Agarwal, DM Dr. Agarwal has nothing to disclose.
Ali Freitekh Mr. Freitekh has nothing to disclose.
Yavor Yalachkov The institution of Yavor Yalachkov has received research support from Heinrich und Erna Schaufler-Stiftung. Yavor Yalachkov has received personal compensation in the range of $0-$499 for serving as a Lecturer with The Medical Association of Hesse. Yavor Yalachkov has received personal compensation in the range of $0-$499 for serving as a Speaker with RG Gesellschaft für Information und Organisation mbH. Yavor Yalachkov has received personal compensation in the range of $500-$4,999 for serving as a Speaker with Roche.
Carolin Otto, MD Dr. Otto has nothing to disclose.
Kathleen Blondeau, PhD Dr. Blondeau has received personal compensation for serving as an employee of F. Hoffmann-La Roche.
Arash Salardini, MBBS Dr. Salardini has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Biogen. The institution of Dr. Salardini has received research support from NIH/NIA. The institution of Dr. Salardini has received research support from Taylor Family. Dr. Salardini has received publishing royalties from a publication relating to health care.
Scott Baver, PhD Dr. Baver has received personal compensation for serving as an employee of Apellis.
Christina N. Fournier, MD Dr. Fournier has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Fournier has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roon. Dr. Fournier has received personal compensation in the range of $500-$4,999 for serving as a Consultant for QurAlis. Dr. Fournier has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Springer Journals. The institution of Dr. Fournier has received research support from Veterans Affairs. The institution of Dr. Fournier has received research support from Department of Defense. The institution of Dr. Fournier has received research support from Amylyx. The institution of Dr. Fournier has received research support from Biogen. The institution of Dr. Fournier has received research support from MT Pharma. The institution of Dr. Fournier has received research support from Columbia University. The institution of Dr. Fournier has received research support from Denali.
Aarushi Suneja, MD Dr. Suneja has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abbvie. Dr. Suneja has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Abbvie.
Damian Michael May, Other Dr. May has received personal compensation for serving as an employee of Acadia Pharmaceuticals. Dr. May has stock in ACADIA Pharmaceuticals. Dr. May has stock in Medtronic. Dr. May has stock in Johnson & Johnson. Dr. May has stock in Pfizer Pharmaceuticals.
Yasar Alejandro Torres-Yaghi, MD Dr. Torres-Yaghi has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Acorda. Dr. Torres-Yaghi has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Abbvie. Dr. Torres-Yaghi has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Amneal. Dr. Torres-Yaghi has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Abbott. Dr. Torres-Yaghi has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Kyowa Kirin. Dr. Torres-Yaghi has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Teva. Dr. Torres-Yaghi has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Sunovion .
Christian Lachner Christian Lachner has nothing to disclose.
Rulan Shaath, Other Miss Shaath has nothing to disclose.
Margaret Elizabeth Upchurch, MD Dr. Upchurch has nothing to disclose.
Rodolfo Savica, MD, PhD, FAAN The institution of Dr. Savica has received research support from ACADIA Pharmaceuticals, Inc.
Julie Falardeau Julie Falardeau has nothing to disclose.
Colleen Marie Buhrfiend, MD Dr. Buhrfiend has nothing to disclose.
Sarah Haars, MD Ms. Haars has nothing to disclose.
Andreas Straube Andreas Straube has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for TEVA. Andreas Straube has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Andreas Straube has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi. Andreas Straube has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Teva. Andreas Straube has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Allergan. Andreas Straube has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Novartis. The institution of Andreas Straube has received research support from German research Counci (BMBF).
Luis Brieva Ruiz, MD Dr. Brieva Ruiz has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for All comercial companies interested in Multiple Sclerosis. Dr. Brieva Ruiz has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Al comercial companies in Multiple Sclerosis. The institution of Dr. Brieva Ruiz has received research support from Carlos III Institut. Madrid. Spain..
Dhruv Patel Mr. Patel has nothing to disclose.
Cynthia Zheng, MD Ms. Zheng has nothing to disclose.
Daniella Alejandra Bustamante, MD Dr. Bustamante has nothing to disclose.
Seyedeh Nasim Cheraghi, MD Dr. Cheraghi has nothing to disclose.
Andrew Tarr, MD Dr. Tarr has nothing to disclose.
Susanna Asseyer, MD Dr. Asseyer has received personal compensation in the range of $0-$499 for serving as a speaker with Alexion. Dr. Asseyer has received personal compensation in the range of $0-$499 for serving as a speaker with Roche Pharma AG. Dr. Asseyer has received personal compensation in the range of $0-$499 for serving as a speaker with Bayer AG.
Bo *Use 381444 Zhang Bo Zhang has nothing to disclose.
Ethar Hazaimeh, MD Dr. Hazaimeh has nothing to disclose.
Diana Angelika Olszewska, MD, PhD Dr. Olszewska has nothing to disclose.
Teresa V. Corona Vazquez, MD Dr. Corona Vazquez has received research support from Consejo Nacional de Ciencia y Tecnologia.
Andrew Grande Andrew Grande has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Medtronic.
Christina Tan, MD Dr. Tan has nothing to disclose.
James Maurice Youakim, MD Dr. Youakim has received personal compensation for serving as an employee of Acadia Pharmaceuticals. Dr. Youakim has stock in Acadia Pharmaceuticals.
Kye Won Park, MD Dr. Park has nothing to disclose.
Caroline K. Geiger, PhD Dr. Geiger has received personal compensation for serving as an employee of Genentech, Inc. Dr. Geiger has stock in Moderna. Dr. Geiger has stock in Abbott Laboratories. Dr. Geiger has stock in Gilead Sciences. Dr. Geiger has stock in Amgen. Dr. Geiger has stock in Roche. Dr. Geiger has received research support from National Science Foundation.
Meghana Karnik-Henry Meghana Karnik-Henry has received personal compensation for serving as an employee of Lundbeck.
No disclosure on file
Linus Jonsson, MD,PhD Prof. Jonsson has received personal compensation for serving as an employee of H. Lundbeck A/S. The institution of Prof. Jonsson has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for H. Lundbeck.
Mefkure Eraksoy, MD Dr. Eraksoy has nothing to disclose.
Javier Sotoca Fernandez No disclosure on file
Bakhtawar Ahmad, MBBS Dr. Ahmad has nothing to disclose.
Edoardo G. Spinelli, MD Dr. Spinelli has nothing to disclose.
Lynda Krasenbaum Lynda Krasenbaum has received personal compensation for serving as an employee of Teva Pharmaceuticals.
Adriana Lazarescu, MD, FRCPC No disclosure on file
Deepa Dongarwar, MS Deepa Dongarwar, MS has nothing to disclose.
Matthew Robert Kennis Mr. Kennis has received personal compensation for serving as an employee of Neurocrine Biosciences. Mr. Kennis has stock in Neurocrine Biosciences.
Erin Harrison Britt, MD Dr. Britt has nothing to disclose.